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Abstract
Numerous chemical species are important to the health of biological systems. Some
species can be beneficial at low doses and harmful at high doses. Other species are highly
reactive and trigger serious cell damage. Improved methods to detect the presence and activity
of such species are needed. In this work, several biologically important species were studied
using appropriate analytical techniques.
Fluoride is an important species in human physiology. It strengthens teeth and gives
protection against dental caries. However, elevated concentrations of fluoride in the body can
lead to health problems such as dental and skeletal fluorosis. Reported fluoride sensors used
fluorescence quenching methods in determining fluoride concentration. Our study explored
synthesis and characterization of 1,8-bis(phenylthioureido) naphthalene (compound 1) as a
fluoride sensing molecule. Compound 1 showed a remarkable 40 fold enhancement in
fluorescence with 5 eq of fluoride addition. Compound 1 also showed possibility of visual
colorimetric sensing with fluoride.
Free radical mediated oxidations of biomolecules are responsible for different
pathological conditions in the human body. Superoxide is generated in cells and tissues during
oxidative burst. Moderately reactive superoxide is converted to peroxyl, alkoxyl and hydroxyl
radicals by various enzymatic, chemical, and biochemical processes. Hydroxyl radical imparts
rapid, non specific oxidative damage to biomolecules such as proteins and lipids. Superoxide
also reacts with nitric oxide in cells to yield peroxynitrite, which is highly reactive and damages
biomolecules. Both hydroxyl radical and peroxynitrite readily react with amino acids containing
aromatic side chains.

xxi

Low density lipoprotein (LDL) carries cholesterol in the human body. Elevated
concentration of LDL is a potential risk factor for atherosclerosis. Previous research drew a
strong correlation between oxidized low density lipoprotein (ox-LDL) and plaque formation in
the arterial wall. More importantly, oxidative damage causes structural changes to the LDL
protein (apo B-100) which might facilitate the uptake of LDL by macrophages. In this study
LDL was exposed to various concentrations of hydroxyl radical peroxynitrite and hypochlorite.
Thereafter oxidized amino acid residues in apo B-100 were mapped by LC-MS/MS methods. We
found widely distributed oxidative modifications in the apo B-100 amino acid sequence.

Keywords: fluoride, fluorescence enhancement, thiourea, chromogenic sensing, low
density lipoproteins (LDL), Fenton Chemistry, free radicals, hydroxyl radical, peroxynitrite,
hypochlorus acid, surface mapping, proteomics, LC-MS/MS, natural variants
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Chapter 1.
Introduction to fluorescence enhancement based fluoride sensing
1.1. Fluoride - friend or foe?
Fluoride is one of the most important elements of the periodic table. It belongs to the
halogen family (Group 17) of elements and showed high electronegativity. American Dental
Association (ADA) and World Health Organization (WHO) identified fluoride as one of the
most important elements in maintaining dental health.1 It helps in preventing dental caries. It also
gives protection against several other teeth and gum related diseases. Extensive research was
done on the ability of fluoride to prevent and combat against dental caries.2 This protection can
be achieved by multiple ways. Three chief mechanisms were previously reported in the
literature.2-6
•

Inhibiting bacterial metabolism: Bacterial infection in the plaque region reduces the pH
of the plaque significantly. Fluoride from the plaque fluid readily combines with H+ and
yields HF. HF diffuses through the bacterial cell wall, acidifies the cell and releases
fluoride ion which inhibits enzymatic activities (enolase) inside the cell. The process
becomes cumulative due to the trapped fluoride.5, 7

•

Inhibiting demineralization of the surface: Dentin or enamel crystals markedly adsorb
fluoride in their crystal surfaces thereby prevent dissolution of the teeth by acid.
Supplemental fluoride plays a critical role in this process. Incorporated fluoride is not
sufficient to prevent dental caries and fluoride supplement all through out the life span is
necessary2, 4 for maintaining dental health.
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•

Remineralization of the surface: In the cary lesion, fluoride from topical sources helps
in nucleating and remineralizing the partially demineralized surface by forming
fluorapatite [FAP: Ca10(PO4)6F2] which is less soluble than carbonated hydroxyapatite.6
However, elevated concentrations of fluoride can lead to several physiological symptoms.

Long term exposure to fluoride may cause dental, skeletal and crippling skeletal fluorosis. In
severe cases it leads to mottled and disfigured teeth. Also it increases bone density in case of
skeletal fluorosis. Therefore it makes the bone fragile and susceptible to fracture particularly at
the joints. One of the major problems with fluoride in the physiological system is the inability of
the system to remove fluoride by biochemical pathways.
Also, high concentrations of fluoride can initiate multiple problems in plants, aquatic and
marine environment. Aluminum fluoride can also play critical role in cellular biochemistry of
plants and animals.8
Additional resources provided results that were even more alarming and uncomforting.
Ayoob & Gupta’s most informative review9 on fluoride contaminated ground water revealed that
long term exposure to low level of fluoride (0.5, 0.7, 2.8 ppm) can cause wide geochemical
disease such as fluorosis. An interesting recent review on a book was published in Chemical and
Engineering News10 regarding fluoridation of water.11 Unfortunately, the book could not remain
unbiased. It was coined that the book instead of revealing a clear picture took sides in favor of
fluoridation.
In recently published notes, the World Health Organization (WHO) recommended the
fluoride level of drinking water should be 1.5 mg/L (ppm).1 Interestingly, United States
Environmental Protection Agency (EPA) does not regulate the addition of fluoride to water.
EPA’s Safe Drinking Water Information System (SDWIS) actively tracks fluoride concentration

2

only in water systems with naturally occurring fluoride level above the established regulatory
limits (≥2.0 ppm).12
The objective of this research, in this regard, is not to raise a new debate on fluoride, but
rather to emphasize the fact that the concentration of fluoride is extremely important in
physiological and environmental systems. Improved analytical methodology is necessary to
address some of the related problems in fluoride detection.

1.2. Fluoride Detection
Anions are important in physiological and environmental systems13-17. Various methods
exist for determination of fluoride and other anions in solutions.13, 18, 19 Most commonly used
methods are ion selective electrodes (ISE)20,

21

and photoluminescence. Photoluminescence

methods are based on absorbance and fluorescence. In this chapter we will mostly discuss
fluorescence based methodologies over other methods.

1.2.1. Ion selective electrode based detection of fluoride
Lanthanum fluoride, LaF3 is widely used as a crystalline membrane electrode for
determining the fluoride ion.22 Europium fluoride (EuF2) can enhance its semiconductor
property. The mechanism of the development of fluoride sensitive response (potential) are very
similar to glass or pH sensitive membranes. In short, in the membrane interface ionization
creates a charge on the membrane surface as shown by the following scheme (Scheme 1.1). The
magnitude of the charge depends on the activity (commonly termed as concentration) of the
fluoride ion in solution.
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Scheme 1.1. Dissociation of LaF3 in membrane electrode.

Commercially available LaF3 electrodes are rugged and can be operated in the range of 0
– 80 °C. The response is linear down to micromolar (106 M ~ 0.02 ppm) concentration.22 The
anionic interferences come from hydroxide ion. Other polyvalent cations can interfere in the
measurements too by disrupting the chemical equilibria for the fluoride in solution. Basicity of
F¯ can cause problems at lower pH. Thus the measurements for ISE’s are best within the pH
range of 5 – 9. Also, ISE theoretically measures activity of the ions in solutions not the actual
concentration.
Fluorescence based anion detection were a popular alternative to ISE in determining
anions in solutions. Both fluorescence and absorbance methods are extensively employed to
determine fluoride and other anion affinity towards various organic chromophores.

1.2.2. Fluorescence basics
Matter can absorb and re-emit light by the phenomenon called luminescence.
Fluorescence and phosphorescence are the two different types of luminescence. Fluorescence
involves emission from a singlet excited state to a singlet ground state. In phosphorescence, the
emission involves a transition from a triplet excited state to a singlet ground state. Beacause the
spin flip results in a forbidden transition, the lifetime of phosphorescence is considerably longer
than that for fluorescence. Fluorescence lifetimes are around 10-8 sec, while those for
phosphorescence are 10-3 to 1 sec or sometimes even longer. Most interestingly, in fluorescence,
the energy of the emitted photons is at longer wavelength than that of the absorbed photons.
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Some of the absorbed energy of the photons was channeled into other processes (vibrational
level, phonons, thermal energy). The resulting emission wavelength is therefore longer (lower
energy). The process is detailed in the energy diagram below called Jablonski diagram (Figure
1.1).22, 23
A photon with frequency ν and energy hνa was absorbed by the ground state (S0)
fluorophore (fluoresceing moiety) (typically 10-15 sec) and reached its singlet excited state S1 or
S2. At higher energy levels internal conversion (10-12 sec) occurs when the photons passes from
higher vibronic level to lower vibronic levels (blue dotted arrows). Also non radiative (red dotted
arrows) processes are associated with transfer of photons from high energy singlet state S2 to
lower energy singlet state S1. In short, the molecule will partially relax and reach the excited
state singlet state S1. It can further relax back to the ground state by emitting a photon of energy
hνf (which is of longer wavelength and lower energy than hνa) and show fluorescence
(represented by solid green arrow). Stokes shift is described as a shift to longer wavelength due
to vibrational relaxation and internal conversion. Fluorescence lifetime typically is 10-5 seconds
or shorter.
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Figure 1.1 Jablonski diagram.
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In phosphorescence, through an inter system crossing (ISC), a spin conversion of the
molecule from excited state singlet S1 to its triplet state (T1). This transfer represents a spin
forbidden transition. Due to spin-forbidden transition, phosphorescence (represented by a navy
blue arrow) lifetime is much longer than that of fluorescence life time. Chemiluminiscence is a
related emission process in which the excited state is achieved through a chemical reaction
instead of a photon absorbance. Once formed, the electronic excited state in chemiluminiscence
behaves the same as those observed in fluorescence.
Fluorescence has several different advantages over other analytical techniques.20-23 It is a
non-invasive technique in the first place. The detection limit can easily reach nanomolar to subnanomolar levels. Fluorescence gives at least one to three orders of magnitude better detection
limits than that of absorbance.23 Also fluorescence has longer linear dynamic range compare to
absorbance spectroscopy. Fluorescence is also more selective because not all compounds
fluoresce. The compounds which show fluorescence have characteristic emission wavelength.

1.2.3. Example of typical fluorescence spectra
A fluorescence emission spectrum is obtained by scanning emission wavelength with a constant
excitation wavelength (often at the absorbance maximum). An excitation spectrum can be
obtained by scanning the excitation wavelength while keeping the emission wavelength constant.
An idealized depiction of the excitation and emission spectrum is shown above. The peak-topeak distance between excitation and emission maximum was considered as Stokes Shift (Figure
1.1).
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Figure 1.2 An idealized fluorescence spectrum was shown. Both excitation and emission scans were depicted.
Stokes shift was also pointed out.
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1.2.4. Benefits of fluorescence measurements
Fluorescence measurement exhibits some outstanding benefits over absorbance
techniques, primarily because it is based on a dark background. In a typical fluorescence
spectrophotometer the detector is placed at a 90° angle relative to the light source (Figure 1.3),
while in absorbance the setup is 180°. A 90° configuration minimizes the transmission and
reflection of non-fluorescent light reaching the detector. In other words scattered light does not
interfere with the experiment.22 The signal to noise (S/N) ratio is substantially enhanced, and an
approximately 10,000 times better detection limit can be achieved with a 90° setup.22,

23

The

excitation and emission monochromators are wavelength selectors which allow specific
wavelength to pass before and after the fluorescence events. Most interestingly, fluorescence
detection is highly sensitive due to a cyclic process which gives the instrument a better detection.
The same fluorophore when excited in a cyclic way can release thousands of photons during
detection. For absorbance the cyclic method does not yield any improvements since the detector
is in the same line with the light source.
Several different factors contribute to the fluorescence of a particular moiety. In general,
a rigid structure, extended conjugation and planarity in the fluorescing moiety play a crucial role
for a fluorophore to fluoresce.24 In addition; excitation and emission spectra also depend upon
the micro-environment and type of solvent used.19
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Figure 1.3 Schematic of a fluorescence spectrophotometer. A 90° angle between incident light and the emitted
light was depicted in the picture. Monochromators are wavelength selectors for excitation and emission
beams.22

10

1.2.5. Fluorescence quenching and enhancement
The Term fluorescence quenching is related to the decrease in fluorescence of a
fluorescing moiety by any process. Several different processes including excited state reaction,
molecular rearrangements, energy-transfer, ground state complex formation and collisional
quenching can cause quenching of fluorescence signal.23
Collisional quenching is often termed as dynamic quenching as it involves the direct
encounter of the excited state fluorophore to the quencher in a dynamic way. When the
fluorophore interacts very strongly with the quencher and forms a non-fluorescent complex, it is
known as a static quencher.23 However, increase in fluorescence after complexation between the
fluorophore and the interacting ligand can also occur and has advantages. Such interactions
improve the signal to noise ratio. A lower limit of detection can also be achieved in the case of
fluorescence enhancement compared to quenching. Fluorescence reveals pertinent information
about the change in the electronic and molecular configuration during the fluorophore-ligand
interaction.

1.3. Urea and thiourea in anion sensing
Hydrogen bonding was depicted as one of the most crucial events in anion sensing with
urea and thiourea.18, 19, 25-31 Highly electronegative atoms such as oxygen, nitrogen and fluorine
interact strongly with hydrogen forming a stronger interaction than dipole-dipole interactions.
The interaction is however weaker than the regular ionic or covalent bond. Previous researches
revealed the potential hydrogen-bond (H-bond) donor capability of urea and thiourea.19, 26, 27, 30-32
Both Urea and thiourea make strong H-bonds with dicarboxylates and hydrogen phosphates.
Urea based receptors were exploited for various other applications including anion sensing.
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Stephan and co workers33 incorporated urea bond in lipophilic dendrimers. These unique
dendrimers showed classical host-guest chemistry in separating anions from aqueous solutions33.
Xie and co-workers34 reported a tripodal naphthylurea based moiety which fluoresces selectively
in the presence of dihydrogen phosphate (H2PO4¯ ). Nam et. al.35 explored a calix[4]diquinone
compound where urea is appended in the structure of the compound. Interestingly, this
compound showed selective affinity towards HSO4¯ over H2PO4¯ , Cl¯ and CH3CO2¯ . In a
related but slightly different subject, a complex calix[4]arene based thiourea compound was
synthesized which showed better efficiency in transporting CsCl and KCl than other cation or
anion receptors.36

1.4. Fluoride Sensing
Over the past few decades, several different fluoride sensing molecules were reported in
the literature.13,

17-19, 25, 37, 38

Boron, aluminum and calixarene based compounds showed

promising results. Yamaguchi and coworkers reported a boron based anthracene compound
where the boron π-orbital accepts electrons from fluoride39 (Figure 1.4). The extensively
conjugated boron anthracene compounds were highly colored. With these compounds,
fluorescence quenching was observed with fluoride. Also a dramatic color change indicated the
possibility of colorimetric anion sensing. Chiu et. al. reported another cationic borane which
showed interaction between boron and fluoride via H-bonding.41.
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Figure 1.4 Boron based analogue by Yamaguchi et. al.39 and aluminum based analogue reported by Badr et.
al.40

Aluminum binds strongly to fluoride. Aluminum porphyrin based compounds can be
useful in sensing fluoride in solution. A thin polymer based sensor using aluminum (III)
octaethylporphyrin was reported (Figure 1.4) that can detect fluoride in the micromolar to
submicromolar range. This methodology, however, was based on absorbance detection.40
NO2

NO2

N

N
N

N
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NH

HN

Figure 1.5 Calixarene based fluoride sensing molecule reported by Kim et. al.42
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Several different calixarene based molecules functionalized by urea and thiourea moieties
were reported in the last two decades. Kim et. al. reported more than one calix[4]arene molecule
which can behave as cation as well as anion sensors.43 In 2006, a urea functionalized
calix[4]arene based molecule was synthesized (Figure 1.5) which showed excimer emission as
well as an increase in fluorescence in the presence of fluoride.44 However, it was apparent that
the amount of fluoride added was significantly high. Esteban-Gomez et. al. reported urea based
supramolecular compounds which showed color development in the presence of various
anions.26

Figure 1.6 Various thioureido analogues reported by Gunnlaugsson et. al.19,
receptors and thalimide based receptors were reported.

27, 45

. Both anthracene based

Ureido protons are somewhat acidic in nature. Highly basic anions such as fluoride or
acetate can easily abstract two hydrogen atoms from the urea bond. Although absorbance
represented poor detection limit compare to fluorescence, the possibility of chromogenic sensing
had revealed some interesting new sights in urea based sensing. Gunnlaugsson’s pioneering work
in the area of anion sensing19, 27, 45 incorporating urea and thiourea in supramolecular structures
(Figure 1.6) revealed several interesting facts. Most of these urea and thiourea based compounds
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interact strongly with fluoride by strong hydrogen bond formation involving the ureido or
thioureido hydrogens. In the same context these groups also reported several different
naphthalimide based receptors which can be used for fluoride sensing based on absorbance as
well as fluorescence.19 These receptors work following the photoinduced electron transfer (PET)
mechanism.45 Several anthracene and naphthalimide based urea and thiourea moieties (Figure
1.6) were studied for fluoride, acetate, hydrogen phosphate and other halides. Both absorbance
and fluorescence results were presented for ureido and thioureido compounds. The majority of
these compounds showed PET based quenching which was originated from fluoride binding
leading to conformational changes in the respective compounds.19
H3 C

O
N

H3 C

HN

NH
NH
S
NO2

Figure 1.7 Thiourea compound reported by Nie and co-workers31. The compound showed fluorescence
enhancement with acetate and fluoride.

Nie and coworkers31 over the years reported several phenyl thiourea based compounds
(Figure 1.7) which showed fluorescence enhancement or quenching in the presence of acetate
even over fluoride.28, 30, 31 In most cases a clearly defined isosbestic point23 was observed after
addition of the host. This indicated the change in conformational structure after binding to the
host. Some of these studies showed fluorescence enhancement in presence of the analyte.
Detection limit for various hosts lie in the range of micromolar to submicromolar range.
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Scheme 1.2 Synthesis of 1,8 bis-(phenylureido) naphthalene analogue as presented by Xu et. al.46 and Cho et.
al.47

Scheme 1.3 Synthesis of 2,3 bis-(phenylureido) naphthalene analogue reported by Xu et. al.46

Naphthalene is a substantially rigid molecule with extended conjugation. Cho et. al.47
studied phenylurea immobilization on diaminonaphthalene based systems. Their work was
focused on chromogenic sensing of anions. Therefore the research was mostly emphasized on
absorbance measurement while the whole new vista of fluorescence remained unexplored. Xu et.

al.46 synthesized phenylurea analogues of 1,8-diaminonapththalene (Scheme 1.2) and . 2,3diaminonaphthalene (Scheme 1.3). 1,8-bis(phenylureido)naphthalene showed fluorescence
enhancement with fluoride while the 2,3-analogue did not reveal any promising results. It was
indicated that the presence of fluoride could induce planarity to the 1,8-analogue to yield
extended conjugation and fluorescence enhancement. Jose and coworkers48 reported urea and
thiourea based anthraquinone compounds (Figure 1.8) which can act as a fluoride sensing
molecule. A pronounced variation in the absorbance spectra was observed after addition of
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fluoride to the respective ureido and thioureido analogues. However fluorescence behavior of the
mentioned ureido and thioureido analogues were not explored extensively in Jose’s study.

HN
O

HN

X
H
N

H
N
X

O

X : O, S
Figure 1.8 Anthraquinone ureido and thioureido analogue reported by Jose et. al.48

Considering

the

above

mentioned

approaches

we

have

synthesized

1,8-

(bisphenylthioureido)naphthalene49 (Compound 1) as a potent fluoride sensing molecule (Figure
1.9). The compound was characterized by 1H,
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C NMR and MALDI-Mass spectrometry.

Fluorescence experiments were performed on the compound in the presence of fluoride and other
halides. Acetate and hydrogen phosphate were also added. A remarkable 40 fold enhancement in
fluorescence signal was observed in the presence of 5 equivalence of fluoride in acetonitrile.49 It
was selective to fluoride over other halides. Hydrogenphosphate and acetate did show
enhancement in fluorescence, but the increase in fluorescence signal was small compared to
fluoride. From the structure it is evident that four thioureido protons can interact strongly with
fluoride, which is small and has a high charge density.
In addition, Compound 1 (Figure 1.9) showed promising results (Chapter 2) in the area
of visual colorimetric chromogenic sensing.49 The solution of compound 1 changed color (a
bathochromic shift was observed in the absorbance spectra) upon addition of 10 equivalent of
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fluoride in acetonitrile. The change in color was visually perceptible at high concentration of
fluoride.

NH
S

HN

NHHN

S

Figure 1.9 1,8-bis(phenylthioureido)naphthalene (Compound 1).

Binding affinity of fluoride to the thioureido protons were discussed in previously
published articles.19,

44

Plausibly, the twisted structure of naphthalene, particularly after

isothiocyanate immobilization, could achieve higher degree of planarity in the presence of
fluoride ion. Fluoride being small could gain a high degree of accessibility to the thioureido
protons thereby enhancing the ability to form strong H-bond with the molecule. Remarkable
fluorescence enhancement after addition of fluoride to compound 1 suggests that interaction
with fluoride was forcing the twisted structure to become planar. In ureido compounds energy
minimization calculation (AM 1) supports the conformational changes around the naphthalene
ring for better planarity.46 In anthraquinone based thioureido analogues Jose et. al.48 calculated
relevant energy minimization data (AM 1). Jose’s calculation revealed the insight that fluoride,
being the smallest among the halides, will reach closer to the thioureido protons. The other
halides being bigger could not fit themselves properly in the space near thioureido protons.

Compound 1 gives several advantages over the other reported fluoride sensing
molecules. While a large number of fluoride sensing molecule were based upon fluorescence
quenching19,

50

or absorbance,47,

51

compound 1 showed fluorescence enhancement in the

presence of fluoride. No other halides interfere in this detection. Very high concentrations of
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acetate or hydrogen phosphate can interfere slightly, although it can not completely undermine
the detection limit of compound 1.
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Chapter 2.
Fluoride detection based on fluorescence enhancement of
naphthalene thioureido derivative
2.1. Abstract
A novel thioureido naphthalene derivative was synthesized and characterized. The
compound proved itself as an effective fluoride sensor with respect to selectivity and sensitivity.
In acetonitrile, the fluorescence intensity increased 40 fold with addition of 5 equivalents of
fluoride. Fluorescence intensity did not substantially change with other halides, suggesting that
the thioureido protons interact strongly with fluoride but not with other halides. The enhanced
fluorescence is due to increased quantum efficiency of the fluoride complex.
Keywords: Fluoride sensing; thioureido compound, fluorescence

2.2. Introduction
Anions play various important roles in biological and environmental processes in
nature.1-6 Though considerable attention has focused on the selective detection of anions using
visible colorimetric sensors,7-19 less progress has been made with the more powerful technique of
fluorescence. Fluoride sensing is important since fluoride plays crucial roles in dental caries20
and other medical issues such as osteoporosis.21 Excess fluoride however causes fluorosis,22-25 a
type of fluoride toxicity that is typically related to an increase in bone density. The important
consequences of elevated and depleted fluoride concentration make effective fluoride sensing an
important tool. Though a series of fluoride sensor compounds have already been reported7, 9, 12, 13,
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15-17, 26-41

by various researchers, there remains a strong practical impetus to improve the

detection at micromolar to submicromolar30 levels. In addition past research mainly focused on
urea based sensors27-29, 31 while the whole new vista of novel thiourea based sensors12, 15, 16, 36, 40,
41

was largely unexplored (Chapter 1). We therefore synthesized (Scheme 2.1) and characterized

1,8-bis(phenylthioureido)naphthalene as a fluorescent probe for fluoride detection as well as a
chromogenic fluoride sensor. The structure of compound 1 was confirmed by 1H (Figure 2.1) and
13

C NMR (Figure 2.2) and mass spectral analysis (Figure 2.3). In the presence of fluoride, this

compound shows a new fluorescence peak (with λmax = 447.5 nm), as shown in Figure 2.4.
Chloride (Figure 2.5), bromide (Figure 2.6) or iodide (Figure 2.7) addition did not cause any
change in the fluorescence intensity or shape.

S
NH2

NH 2

N

C

NH

Et3N, RT, 24Hrs

S

HN

NH HN

S

THF

Scheme 2.1 Synthesis of 1,8-bis(phenylthioureido)naphthalene (Compound 1).
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Figure 2.1 1H NMR spectra for compound 1. Frequency calculation data can be viewed at the end of the chapter in selective data for compound 1
section. DMSO was used as a NMR solvent. Two thioureido protons were missing from the spectra due to rapid exchange with the solvent.
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Figure 2.2 13C NMR data for compound 1. Frequency calculation data can be viewed at the end of the chapter in selective data for compound 1 section.
DMSO was used as NMR solvent.
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Figure 2.3 MALDI-Mass spectrum of compound 1 in presence of 0.1 (M) AgNO3 solution. Mass of compound 1 is 428 amu. 535 amu and 537 amu
masses were observed indicating the silver adduct formation.
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Figure 2.4 Fluorescence spectra on fluoride addition to compound 1 in acetonitrile. Initial concentration of compound is 50 µM. Fluoride was added in
12.5 µM increments. Excitation wavelength = 345 nm; emission maximum = 447.5 nm.
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Figure 2.5 Effect of chloride on compound 1 (50×
×10-6 M). 1 eq chloride per addition. A total of 9 eq of
chloride was added. No perceptible change in the signal was observed.
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Figure 2.6 Effect of bromide on compound 1 (50×
×10-6 M). 1 eq bromide per addition. A total of three eq of
chloride was added.
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Figure 2.7 Effect of iodide on compound 1 (50×
×10-6 M). 1 eq iodide per addition. A total of three eq of chloride
was added.

However, a fluorescence response to dihydrogenphosphate (Figure 2.8) and acetate
(Figure 2.9) has been observed, although the response to fluoride is substantially higher than that
for these other anions. The fluorescence response to nine equivalents of dihydrogenphosphate is
approximately equal to that observed for one equivalent of fluoride. Similarly, nine equivalents
of acetate yielded a fluorescence signal that was approximately equal to addition of two
equivalents of fluoride1. Separate experiments showed that even in the presence of 1 mM
dihydrogenphosphate (Figure 2.10) or 1 mM, acetate (Figure 2.11) compound 1 still showed
enhancement in fluorescence with addition of 0.25 equivalent of fluoride.

While some

interfering signal may result from the presence of these anions, the response to fluoride is not
inhibited by their presence.
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Figure 2.8 Effect of dihydrogenphophate (H2PO4¯ ) on compound 1 (50×
×10-6 M). 1 eq H2PO4¯ per addition. A
total of ten eq of H2PO4¯ was added. Slight increase in the signal was observed.
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Figure 2.9 Effect of acetate on compound 1 (50×
×10-6 M). 1 eq acetate per addition. A total of ten eq of acetate
was added.
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Figure 2.10 Fluorescence enhancement with fluoride in presence of 1mM dihydrogenphophate (H2PO4¯ ) on
compound 1 (50×
×10-6 M). 0.25 eq of fluoride per addition. A total of 2.5 eq of fluoride was added. Significant
fluorescence enhancement after fluoride addition was observed.
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Figure 2.11 Fluorescence enhancement with fluoride in presence of 1mM acetate (CH3COO¯ ) on compound 1
(50×
×10-6 M). 0.25 eq of fluoride per addition. A total of 2.5 eq of fluoride was added. Significant fluorescence
enhancement after fluoride addition was observed.
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A titration experiment (1H NMR) showed substantial changes upon addition of fluoride.
The thioureido proton signal decreased rapidly and broadened with addition of fluoride (Figure
2.12). No significant changes in the aromatic proton signals were apparent. The observed
changes in the thioureido proton NMR signal suggest strong H–bonding between thioureido
protons and fluoride ions with exchange on the NMR time scale. Due to its small size and high
charge density, the fluoride ion had a much stronger interaction with the thioureido protons than
the other halides, resulting in the selective enhancement of fluorescence by fluoride.

Figure 2.12 : Partial 1H NMR (400 MHz) of compound 1 (5 mM) in DMSO-d6 upon the addition of
tetrabutylammonium fluoride: (a) 0 µM, (b) 10 µM, (c) 20 µM, (d) 30 µM, and (e) 40 µM.
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Fluorescence intensity increased significantly with addition of fluoride, while other
halides showed little or no change. An approximate 40 fold enhancement in fluorescence
intensity at 447.5 nm was observed in the presence of 5 equivalents of fluoride (50 µM
compound 1, 250 µM F-). Furthermore, addition of only 0.25 equivalent of fluoride (12.5 µM F-)
resulted in an approximate 1.5 fold increase in fluorescence intensity at 447.5 nm, indicating that
detection limits in the low to sub micromolar range are possible. UV-Vis absorbance spectra
(Figure 2.13) were acquired to determine if compound 1 can also behave as a chromogenic
sensor. After addition of 10 equivalents of tetrabutylammonium fluoride, a bathochromic shift in
the absorbance spectrum was clearly observable. With fluoride present, the absorbance extended
into the visible region, indicating that detection of fluoride could be carried out colorimetrically,
perhaps even with the naked eye. However, superior detection limits exist using fluorescence
methods.
The data in Figure 2.13 indicate an approximate doubling in the absorbance at 345 nm
upon the addition of excess fluoride. Fluorescence data (Figure 2.4) illustrate an approximate 40
fold enhancement near saturation (the point where all compound 1 molecules are bound to
fluoride). Since fluorescence at low concentration is proportional to absorbance, these data
indicate that only a small portion of the fluorescence enhancement can be accounted for by
increased absorbance. Consequently, we can conclude that the fluoride complex has a larger
quantum yield than unbound 1. Based on the absorbance and fluorescence data, the enhancement
in quantum yield is estimated to be 20 fold. This observation is in agreement with previous
reports which suggested improved planarity29 and lack of relaxation via twisted conformations42,
43

as possible mechanisms for enhanced fluorescence in ureido derivatives.
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Figure 2.13 Absorbance of compound 1 (50 µM) before (green trace) and after 500 µM fluoride addition (red
trace).

A novel thiourea based sensor molecule, 1,8-bis(phenylthioureido)naphthalene, was
synthesized and characterized. The compound showed fluorescent enhancement in the presence
of fluoride. This response was selective for fluoride, with chloride, bromide, and iodide
producing little or no response. The large enhancements in fluorescence (40 fold observed in
this study) suggest that this molecule may provide improved analytical characteristics over
previously described molecules, especially since many other studies have reported molecules that
exhibit either fluorescence quenching in the presence of fluoride14 or show only changes in
absorbance.15, 27, 31, 32 Compound 1 may also be advantageous since its fluoride complex can be
excited in the visible region.
The potential practical applications of compound 1 appear to be versatile and include
fiber optic and nanometric sensors for fluoride. Current work focuses on immobilizing
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compound 1 on a solid support (such as a fiber optic or nanoparticles) for detection of fluoride
in aqueous media.

2.3. Experimental section
All starting materials were purchased and used without further purification.

1

H and 13C

NMR were recorded on a 400 MHz spectrometer operating at 9.4 T. NMR experiments was
carried out in DMSO-d6 with 0.05% v/v TMS. Mass spectra were acquired with a MALDI-TOF
mass spectrometer. Fluorescence experiments were carried out in acetonitrile solution with
excitation wavelength of 345 nm and emission range of 375-550 nm with 7.5 nm slit widths.
UV-Vis absorbance experiments were carried out with quartz cuvettes (path length 1 cm).
2.39 mmol of 1,8-diaminonaphthalene was dissolved in 20 ml dry tetrahydrofuran. Two
drops of triethylamine was added. This mixture was then added drop wise over one hour to 32.5
mmol of phenylisothiocyanate which was dissolved in 20 mL tetrahydrofuran. The system was
kept in a nitrogen atmosphere. The mixture was stirred at room temperature for 24 hours. The
progress of the reaction was monitored by TLC (eluent: 4% acetonitrile in chloroform). The
mixture of the compound was purified by column chromatography (eluent: 4% ACN in
chloroform). The yield was approximately 20-22%.

2.3.1. Selected data for compound 1
MP: 135-137 ΕC decomposed; 1H NMR (DMSO-d6)

11.43 (s, 2H), 7.53 (d, J = 7.8

Hz, 2H), 7.46 (t, J = 7.8 Hz, 2H), 7.28 (t, J = 7.8 Hz, 4H), 7.21 (d, J = 7.9 Hz, 4H), 7.13 (t, J =
7.9 Hz, 2H), 6.67 (d, J = 7.8 Hz, 2H), two additional thioureido protons were not observed due to
exchange; 13C NMR (100 MHz, DMSO-d6) δ 173.7 (q), 140.6 (q), 136.1 (q), 134.8 (q), 129.6 (2
X CH), 129.1 (CH), 122.6 (CH), 119.9 (CH), 119.0 (2 X CH), 116.9 (q), 105.4 (CH); matrix
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assisted laser desorption ionization mass spectrometer (MALDI-MS) showed the silver adducts
(107Ag, 109Ag) at m/z = 535, 537 amu, corresponding to the expected molar mass of 428 amu.
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Chapter 3.
Mapping amino acid oxidations of apolipoprotein B-100 in LDL by
LC-MS/MS and analysis of natural variants: An introduction
3.1. Cardiovascular diseases (CVD) – epidemiology and risk factors
Cardiovascular diseases (CVD) are among the leading causes of death in western
countries. Millions of people die from these diseases every year in the United States (Figure 3.1).
Each year the American Heart Association, in conjunction with several other agencies, publishes
a variety of literature, notes and safe practices for healthy living. Some interesting statistical
updates on CVD are furnished below.

•

The 2006 overall death rate from CVD (was 262.5 per 100,000. The rates were 306.6 per
100,000 for white males, 422.8 per 100,000 for black males, 215.5 per 100,000 for white
females, and 298.2 per 100 000 for black females. From 1996 to 2006, death rates from
CVD declined 29.2%. Mortality data for 2006 show that CVD accounted for 34.3% (831
272) of all 2 426 264 deaths in 2006, or 1 of every 2.9 deaths in the United States.1

•

On the basis of 2006 mortality rate data, nearly 2300 Americans die of CVD each day, an
average of 1 death every 38 seconds. The 2007 overall preliminary death rate from CVD
was 250.4. More than 151,000 Americans who succumbed to death by CVD in 2006
were <65 years of age. In 2006, nearly 33% of deaths due to CVD occurred before the
age of 75 years, which is well before the average life expectancy of 77.7 years.1
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Figure 3.1 Deaths from Cardiovascular diseases chart. A decreasing trend after 1970 could be noted.

Undoubtedly a general mass awareness of cardiovascular diseases is playing a critical
role in decreasing the number of deaths from this disease. The data, however, seems to indicate
that it is still a severe threat to public health in developing and developed countries. According to
the World Health Organizations fact sheet2 on cardiovascular diseases, the annual death toll from
this disease is highest compared to any other disease.
An estimated 17.1 million people died from CVD in 2004, representing 29% of all global
deaths. Of these deaths, an estimated 7.2 million were due to coronary heart disease and 5.7
million were due to stroke.2 Most alarmingly, by 2030, almost 23.6 million people will die from
CVD per year, mainly from heart disease and stroke. These are projected to remain the single
leading causes of death. The largest percentage increase will occur in the Eastern Mediterranean
Region. The largest increase in number of deaths will occur in the Southeast Asia Region.2
In general, CVD are considered as a group of disorders including coronary heart diseases,
cerebrovascular diseases, peripheral arterial diseases, rheumatic heart disease, congenital heart
disease, deep vein thrombosis and pulmonary embolism. Several different behavioral factors
44

contribute to the cardiovascular disease risk factors. Unhealthy diet, physical inactivity and
tobacco use are the chief risk factors.1, 3
It has been understood for many years that diet is an essential component to avoid CVD.
Elevated blood cholesterol was implicated as one of the major risk factors for cardiovascular
diseases.1,

3

Although a recent survey indicated a downward trend in serum cholesterol levels

(Figure 3.2) in people of age 20 and older, elevated cholesterol still poses a considerable threat to
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Figure 3.2 Trends in mean total serum cholesterol among adults of age 20 and older, by race/ethnicity survey.
(NHANES: 1988-94, 1999-02. 2003-04, 2005-06)
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3.2. Low density lipoproteins (LDL)
3.2.1. Lipoproteins
A lipoprotein is an assembly of lipid and protein held together (Figure 3.3) by noncovalent forces.4, 5 Low density lipoprotein (LDL) is one major lipoprotein which is synthesized
in the liver. LDL plays a critical role in cholesterol transport in physiological systems (Figure
3.4). The other lipoproteins are chylomicrons, very low density lipoprotein, intermediate density
lipoprotein and high density lipoproteins (HDL).6,
cardiovascular diseases.3,

8, 9

7

Higher level of HDL helps preventing

LDL serves as a representative of serum blood cholesterol in

medical conditions and is often termed as “bad” cholesterol.3

3.2.2. LDL function
Low density lipoproteins consist of three components. The core is made up of cholesteryl
ester and triacylglycerol, the outer layer free cholesterol and phospholipids. One single
monomeric protein apolipoprotein B-100 (apo B-100) encircles the LDL particle6, 7 (Figure 3.3).
The average molecular weight of LDL particle is approximately 3 million Dalton10. Brown and
Goldstein’s legendary work11, 12 on LDL and LDL receptors earned them a Nobel Prize in the
1980’s. LDL transports cholesterol through circulation. In general, when a cell needs cholesterol,
LDL is transported to the cell (Figure 3.4). There, LDL binds to the LDL receptors (LDL-R)
which are positioned in the cell surface. After binding, the assembly is taken inside the cell by
endocytosis, forming a coated pit followed by a coated vesicle. In the endosome, the assembly
becomes protonated, and LDL receptors break free from LDL. The LDL enters lysozome and is
degraded to release the cholesterol. The protein breaks down to amino acids. The LDL receptors
go through the recycling vesicles and return back to the surface.11
46
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Figure 3.3 Schematic representation of an LDL particle.
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Figure 3.4 Mechanism of LDL uptake by cells in the physiological systems. LDL was included in the cells after binding to LDL receptors. After going
through Lysosomal degradation, cholesterol is released and used in cellular functions.
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3.2.3. Structure of apolipoprotein B-100 in LDL
Apolipoprotein B-100 (apo B-100) stays in the outermost side of LDL (Figure 3.3). This
protein is secreted from the liver and is one of the largest monomeric proteins in existence
(molecular weight = 550 kDa).13-15 It consists of 4563 amino acids (accession # P04114).16 The
structure of apo B-100 is still poorly understood. Due to the enormous size of this protein, it is
rather difficult to determine the crystal structure of this protein. Also, the protein is lipid bound
hence there could be a possibility of structural change if the protein is delipidated during the
structural studies and not represent a true account of the structure. It should be noted that Apo B48 which is an isoform of apo B-100 was found in chylomicrons (stop codon at amino acid
AA2180) and are synthesized in the small intestine.5
Several attempts were made to elucidate the structure of apo B-100 in LDL.5, 14, 17 Despite
some useful information published in the literature over the last two decades, the structure of the
protein is still not lucid. Molecular modeling method, although showing promise, were limited
and speculative in this case particularly due to the size of the protein.10, 18, 19 In homology based
molecular modeling researchers used a putative ancestor of apo B-100 known as lipovitellin
found in egg yolk.10, 20 This protein showed N-terminal matching up to 20.5% and basic local
alignment search tool (BLAST) matching up to 20.8%.21
Apo B-100 is amphipathic (contains both hydrophobic and hydrophilic regions) in nature.
It consists of 3 α-helices and two β-strands in between the α-helices. Generally, the structure is
represented by NH2 – βα1 – β1 – α2 – β2 – α3 – COOH.10, 19, 20 Most interestingly, β-domains
are associated with the neutral lipid core imparting stability to the LDL structure while the αhelices are flexible and are associated with flexibility of the molecule and their intravascular
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mechanism.22 The amphipathic nature of apo B-100 helps it maintain strong lipid binding during
transport through the blood.
LDL lipid oxidations and their implication in atherosclerosis were studied by various
research groups around the world.23-30 However, limited data exists on protein oxidation and the
resulting changes in LDL.31-37 It was thus apparent that oxidation of protein are associated with
the structural changes in apo B-100. These structural changes can be crucial for deposition of
LDL in atherosclerotic plaque formations.

3.3. Free radicals and other oxidants in physiological systems
3.3.1. Reactive oxygen species (ROS): Fenton Chemistry and hydroxyl radical
Free radicals are defined as any atom or molecule bearing unpaired electrons.38 The
presence of unpaired electrons makes free radicals chemically reactive. They can be cationic,
anionic or neutral. In biological systems, oxygen radicals are well known for their broad
spectrum reactivity. Ground state molecular oxygen has two unpaired electrons. Although it
behaves as an oxidant it is relatively unreactive. However, reduction of molecular oxygen
(addition of electrons) yields a broad spectrum of intermediates which showed high reactivity
towards biomolecules.39
Although several parts of the human body could be a source of free radical formation,
mitochondria are the major source of free radical production in cells. Leakage from electron
transport chain or oxidative burst can produce superoxide anion radical.39 Also, partially reduced
mitochondrial components and oxygen tension play important roles in generating superoxide and
other reactive oxygen species.40 Superoxide stays in equilibrium with hydroperoxyl radical. It
can be converted to peroxyl, alkoxyl and hydroxyl radical by various pathophysiological
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processes.40 Cytochrome C oxidase converts oxygen to water thereby eliminating the possibility
of ROS formation in cells. NADPH oxidase, however, promotes the formation of superoxide
from oxygen (Scheme 3.1). Superoxide dismustase disproportionates superoxide to hydrogen
peroxide and oxygen. Also, one electron reduction of superoxide followed by protonation can
lead to hydrogen peroxide formation. Imbalance of hydrogen peroxide can be counter balanced
by catalase and peroxidases. However metal ions can play a critical role in decomposing
hydrogen peroxide to yield hydroxyl radical.41 For example Haber-Weiss reaction is a catalytic
cycle for iron through which hydroxyl radical can appear from superoxide and hydrogen
peroxide.42, 43 All of these radicals, particularly hydroxyl radical, are extremely reactive and can
cause non specific damage to biomacromolecules. The half life of hydroxyl radical is fairly low
(nanosecond range).41, 43-45
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Cytochrome C oxidase
NADPH oxidase, electron transport chain
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Superoxide dismutase
Trx, peroxiredoxin
GSH, glutathione peroxidase
Catalase

Scheme 3.1 Mechanism of formation and detoxification of reactive oxygen species (ROS) in cells.
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In a 1894 article, Henry J. Fenton first described a unique reaction between iron [Fe(II)]
and hydrogen peroxide.46 Haber-Weiss elaborated his method and described formation of
hydroxyl radical from hydrogen peroxide and superoxide anion radical42,
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(Equation 3.1). In

short it is a catalytic cycle for iron by which iron generates hydroxyl radical. Fenton processes
are described as a set of reactions noted below42, 48, 49 (Equation 3.1−Equation 3.6).
Fe

Fe

2

3

H2O2

Fe

H2O2

Fe

3

OH

2

H2O

Equation 3.1

H

Equation 3.2

HO2

Equation 3.3

Equation 3.4

Equation 3.5

Equation 3.6

Equation 3.2 and Equation 3.3 emphasize the catalytic cycle for Fe. The last two
reactions (Equation 3.5 and Equation 3.6) reveal scavenging ability of Fe (II) and hydrogen
peroxide. In physiological systems, sources of “free” iron are fairly limited. Iron storage proteins
such as transferrin, ferritin and hemoglobin have bound iron. However, non-transferrin bound
iron can be considered as “free” iron. These iron species (conc. 1∼10 µM) can bind to citrate or
albumin in blood. Also iron-sulfur clusters can release iron in pathophysiological conditions.43
This released iron can play important roles in generating hydroxyl radical in cells.
A negative free energy change of a system results in the spontaneity of a reaction. Free
energy is directly proportional to the redox potential of the reactant(s). Hence mathematically we
can write Equation 3.7. For spontaneity ∆G must be negative, therefore E should be positive.50 If
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we delve into the redox chemistry of cells we will see that after superoxide is formed all top
down processes were favorable from free energy point of view (Scheme 3.2). Particularly, water
formation from hydroxyl radical is thermodynamically favorable.51

∆G = - nFE

Equation 3.7

Where ∆G: Free energy change
n: # of moles electrons
F: Faraday
E: reduction potential of the cell

-0.18 V
O2

+0.94 V
O2

H2O2

+e, 2H

+0.38 V
Me

HO

+2.33 V
+e, H

H2O

Scheme 3.2 Electrode potentials depicting the reactivity of different ROS. “Me” represents metal cation.
More positive E depicts enhanced spontaneity in the reaction.

3.3.2. Reactive Nitrogen Species (RNS)
Since the discovery of nitric oxide radical as a cellular messenger, vasodilator and
antiatherogenic molecule52-54, its reaction with superoxide anion radical yielding peroxynitrite
became important to explain the cellular toxicity (Scheme 3.3). Together nitric oxide and
peroxynitrite are known as reactive nitrogen species (RNS).40 Reactive nitrogen species in
conjunction with ROS induce cell damage, proliferation and apoptosis.55 Indeed, peroxynitrite is
much more reactive than its predecessor nitric oxide and superoxide in physiological systems.5659

It has been implicated that peroxynitrite plays a pronounced role in atherosclerosis60-63, chronic

inflammation64 and neurodegenerative diseases.65, 66 Due to its powerful oxidizing properties it
reacts readily with biomacromolecules in cells. In particular the damage alters structure and
functions of proteins.
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3.3.3. Peroxynitrite formation and reactions with proteins
Although peroxynitrite can appear in different organs of the body, it is particularly
important in vascular biology for endothelial dysfunction. In endothelial cells, nitric oxide is
synthesized by enzymatic activity of the enzyme endothelial nitric oxide synthase (eNOS).
Endothelial NOS converts L-arginine to L-citrulline and release nitric oxide in the process
(Scheme 3.3). Nitric oxide reacts with endothelial superoxide almost at a diffusion controlled
rate56,
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(1010 M-1s-1) (Scheme 3.3). Under physiological conditions, peroxynitrite stays in

equilibrium with its conjugate acid form peroxynitrous acid56 (ONOOH, pKa: 6.8). ONOOH is
relatively unstable and yields nitrite radical and hydroxyl radical by a homolytic fission pathway.

e-donor
NH
H2 N

N
H

O

O
H2 N

OH
NH2

eNOS

L-arginine

O
N
H

OH
NH 2

L-citrulline

NO

O2

O
N

O

Peroxynitrite

O

Scheme 3.3 Synthesis of nitric oxide from L-arginine in vascular endothelial cells and its reaction with
superoxide to yield reactive peroxynitrite.

One of the most interesting and biologically relevant reactions of peroxynitrite in
physiological system is its combination with carbon dioxide or bicarbonate to yield
nitrosoperoxycarboxylate (Scheme 3.4). Carbon dioxide reacts with peroxynitrite with a second
order rate constant 4.6×10-4 M-1 s-1 at pH 7.4 and 37 °C57 leading to the formation of the adduct
ONOOCO2¯ . This adduct, nitrosoperoxycarboxylate, dissociates into nitrite radical and carbonate
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radical.67 Carbonate radical reacts readily with the side chain of tyrosine residues in proteins to
yield a tyrosyl radical. Reaction between tyrosyl radical and nitrite radical is fast and yields 3nitrotyrosine.63, 68 It is therefore conceivable that sulfur containing amino acids (cysteine) and
aromatic amino acid side chains will react with peroxynitrite by various mechanisms.58, 59, 69, 70
Peroxynitrite decomposition yields radicals such as hydroxyl, nitrite and carbonate. The latter
has high reactivity towards the amino acid side chains as well as the protein back bone.56,
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Homolytic fission probability of peroxynitrite to yield nitrite and hydroxyl radical is <1%
(Scheme 3.4). Therefore peroxynitrite can react directly with biomolecules before homolytic
fission. Although several reactions are feasible, specific markers for peroxynitrite mediated
oxidations are scarce. In fact, 3-NT and nitrotryptohans are the only definitive markers for
oxidations of proteins by peroxynitrite.
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Scheme 3.4 Various reactions of peroxynitrite were depicted in the above scheme. Reaction of dissociation products of nitrosoperoxycarboxylate (a
reaction product of peroxynitrite and carbon-di-oxide) to tyrosine was shown in the inset. Carbonate radical plays important role in the formation of 3nitrotyrosine (3-NT).
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3.3.4. Hypochlorus acid (HOCl)
Similar to peroxynitrtite, hypochlorus acid is not a free radical. However it is a powerful
oxidant that can act on macromolecules. Activated phagocytes release hydrogen peroxide (H2O2)
and superoxide via a respiratory burst along with the heme enzyme myeloperoxidase (MPO).71
MPO catalyzes the reaction between H2O2 and physiologically available chloride to yields
hypochlorus acid.62 Physiologically hypochlorus acid is used as a bacterioside.71,
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However,

excessive and/or off site generation of hypochlorus acid causes serious tissue damage73 and is
believed to be one of the key factors in progression of diseases such as atherosclerosis and
chronic inflammation.32, 33, 68, 74

3.3.5. Biomacromolecule oxidation with HOCl
DNA bases are a major target for HOCl mediated oxidation.75 Unstable chloramines are
formed during this reaction which can initiate further damage. Cholesterol and unsaturated fatty
acids generate cholorohydrin upon treatment with hypochlorus acid which could easily be
detected by GC/MS methods.73 These products, however, were minor since the rate of formation
is relatively slow.76
Proteins are one of the major targets of hypochlorus acid.34, 77, 78 Although oxidation of
side chains of amino acids prevail, peptide backbone fragmentation and aggregation in proteins
were also observed78. Hypochlorite anion is by far more reactive than its protonated form.
Hypochlorus acid targets the protonated amine groups79 in amino acid side chains. Second order
rate constants were reported79 for Cys and Met on the order of 107 M-1 s-1. Cystein forms sulfonic
acid (cysteic acid) and methionine forms methionine sulfoxide during reaction with hypochlorus
acid.78 Oxidation of Trp (indolic residue) and chlorination of Tyr (phenolic residue) are also
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common products.80 Histidine has a slightly higher rate constant (1.0×10-5 M-1s-1)79 than its other
hydrophobic amino acids counterparts. By using a kinetic modeling technique, Pattison et. al.,
reported that the major targets with a slight excess of hypochlorus acid are the side chain
residues of the proteins and not the peptide backbone.78, 79 The ε-NH2 group of lysine is also one
of the major targets for hypochlorus acid. Monochloramines and dichloramines (with high excess
of HOCl) are formed during the reaction of hypochlorus acid and lysine residues. Chloramines
which are mildly oxidizing can transfer chlorine to the other amino acid side chains (such as
tyrosine) and regenerate the parent amine. In Alzheimer’s disease, a particular tyrosine residue
was found to be chlorinated more than the other six Tyr residues in apo A-I. This phenomenon
was attributed to a chlorine transfer mechanism from a nearby lysine residue through a
chloramine intermediate.81 Recently, Pattison et. al. researched on proteins such as insulin and
lysozyme to study chloramine transfer reactions more extensively. These proteins have low
levels of Cys, Met and Trp residues thereby the major kinetic targets for HOCl were eliminated
and chloramine pathway for His and Lys was promoted.82

3.4. Apo B-100 oxidation in LDL
3.4.1. Hydroxyl radical mediated direct oxidation of apo B-100
Free radical mediated protein oxidations were established although not quite well
understood. Since the early 1980’s, Stadtman and coworkers have published pioneering work in
the area of free radical mediated metal catalyzed oxidations (MCO) of amino acids, peptides and
proteins.83-86 These reactions included side chain modifications in amino acids, sometimes
polypeptide backbone fragmentations and cross linking.87-89 Depending upon the degree of
oxidation, the protein can unfold, lose its reactivity and show altered behavior towards
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proteolytic enzymes. Radical mediated damage was always associated with pathophysiological
events such as aging, cancer, diabetes, cataract and atherosclerosis.
Oxidized LDL was implicated as a crucial factor for atherosclerotic plaque formation in
the arterial wall28, 36, 89-97. LDL can be oxidized by two different ways (Figure 3.5). If the radical
site is generated near the protein the radical once formed could easily access the side chain of the
amino acids. It will therefore modify any amino acids that are in the vicinity. On the other hand,
apo B-100 constitutes 20% of LDL particles and the remaining 80% of LDL is comprised of
lipids.6 If the free radical is generated near the lipids, it will oxidize the lipids first (Figure 3.5).
During lipid oxidation, several different lipid peroxides could form which can be converted to
reactive aldehydes such as acrolein or 4-hydroxynonenal (4-HNE).26,

98

These aldehydes are

unsaturated and are nucleophilic in nature. Moreover, the radical such as hydroxyl radical might
be short lived, but secondary reaction products such as aldehydes have fairly long life time and
can damage several different amino acids in proteins.22, 26, 99, 100 Our main interests, however, lie
in the direct damage caused by the radicals.
Recent studies on oxidation of apo B-100 showed that aberrant apo B-100 can interact
with the arterial proteoglycans and initiate plaque formation in the arterial wall.94,

101-105

Moreover, we strongly believe that the site of the oxidation of apo B-100 is one of the key
factors in atherosclerotic plaque formation due to the structure-function relationship for the
protein.
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Figure 3.5 Free radical mediated oxidations of apo B-100 in LDL is shown in the above figure. Protein damage by both direct radical attack and lipid
mediated intermediates were depicted.
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Aromatic amino acids such as phenylalanine (Phe) and tyrosine (Tyr) were considered as
a sink for hydroxyl radical due to their high reactivity towards the radical.106 One simple
characteristic reaction of hydroxyl radical is hydroxylation of the phenyl ring. Products of Phe
oxidation are therefore o-, m-, p- tyrosine and DOPA (Scheme 3.5).
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Scheme 3.5 Oxidation of side chain of phenylalanine residue by hydroxyl radical yielding o-, m-, p- tyrosine
(+16 Da) and dihydroxyphenylalanine (DOPA) (+32 Da).
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Scheme 3.6 Oxidation of the side chain tyrosine residue by hydroxyl radical yielding dihydroxyphenylalanine
(DOPA) (+16 Da).
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Scheme 3.7 Histidine side chain oxidation product after reacting with hydroxyl radical (+16 Da).
Corresponding ketone is more stable and shown in the scheme.

Similarly, Tyrosine predominantly generates 3, 4 dihydroxyphenylalanine (DOPA)
(Scheme 3.6) both in aerobic and in non-aerobic conditions. Direct oxidation product of histidine
(His) yields a complex mixture of products including hydroxylated (Scheme 3.7), carbonyl and
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ring opening products. Tryptophan (Trp) oxidizes to form hydroxytryptophan (not shown) and
the ring opening products kynurenine and N-formylkynurenine (Scheme 3.8).
Reactions of lysine (Lys), arginine (Arg) and proline (Pro) with hydroxyl radical is
considerably fast. In all cases a semialdehyde is the initial product. Oxidation of proline and
arginine leads to glutamic semialdehyde formation107, 108 (Scheme 3.9).

Scheme 3.8 Oxidation of tryptophan to Kynurenine (+4 Da) and N-formylkynurenine (NFK) (+32 Da). These
products appear both in hydroxyl radical mediated oxidation as well as in presence of hypochlorus acid.

Scheme 3.9 Reaction of proline residue (in a generic peptide) with hydroxyl radical and formation of glutamic
semialdehyde (+16 Da).

Lysine oxidation yields aminoadipic semialdehyde85, 109(not shown). Oxidation of these
residues was detected by a sodium borohydride reduction followed by a hydrolysis with
hydrochloric acid. This treatment yielded 5-hydroxy-2-aminovaleric acid (HAVA) (for Arg and
Pro) and 6-hydroxy-2-aminocaproic acid (HACA) (for Lys) which could be detected by GC/MS
methodology.109-111 Also as depicted by Stadtman and coworkers, carbonyl assay could be a
sensitive technique for detecting glutamic and aminoadipic semialdehydes.85 In carbonyl assays,
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classic spectrophotometric methods were used to quantitate the 2,4-dinitrophenylhydrazine
derivatives of carbonyl compounds. Pietzsch detected high levels of HAVA during MCO of LDL
oxidation in vitro.110 Also, sensitive and improved GC/MS based methodologies can identify the
increased level of these carbonyls in cells and tissues in case of pathological conditions such as
aging.109,

111, 112

Unfortunately, neither GC/MS nor other assay based methods can detect the

position of the amino acids in a protein that was oxidized by a free radical.
Most importantly all of these chemical changes are associated with characteristic mass
changes. These mass changes leave specific footprint on the proteins. By using suitable mass
spectrometric based methodologies (LC-MS/MS) the specific oxidation sites could be
determined on the proteins.

3.4.2. Oxidation of amino acid via lipid intermediate
As mentioned earlier in these chapter lipids can be easily oxidized by hydroxyl radical to
form aldehydes such as malondialdehyde, acrolein or 4-hydroxynonenal (HNE). All of these
species are highly reactive electrophiles that can target specific amino acids. Uchida’s pioneering
work on covalent HNE adduct formation with Lys, His and Cys residues provides ample
evidence in support of modification of amino acids in LDL.26,
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These modifications are

associated with structural changes in apo B-100.
Michael addition type products (1, 4 addition) are typical in covalent attachment of HNE
to His residues (+156 Da) (Scheme 3.10). Lysine which has a reactive ε-amine group was a
specific target for acrolein. Acrolein forms heterocyclic adducts such as Nε-(3-formyl-3,4dehydropiperidino) lysine (FDP-Lys) (+94 Da) or Nε-(3-metheyl pyridinium) lysine (MP-Lys)
(+76 Da)26, 98 (Scheme 3.11). Sayre discussed 2-pentylpyrrole adduct formation in Lys residues
through a hemiaminal intermediate formation during reaction with HNE.113 HNE attaches to
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lysine via a Schiff base adduct (1, 2 addition) formation. The Schiff base adduct formation is
associated with characteristic mass increase of +138 Da and +120 Da (Scheme 3.11). HNE-Lys
adducts were sometimes labile.114 Previous attempts to identify the HNE-Lys adduct in proteins
were mostly unsuccessful when trypsin was used as the proteolytic enzymes.115 It is however
apparent that chymotrypsin digestion gives better result in detecting HNE-Lys residues in protein
oxidation.116
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OH

Scheme 3.10 4-Hydroxynonenal adduct (4-HNE) adduct on histidine residue (+156 Da).

Interestingly, Cu (II) mediated oxidations of LDL initially yield lipid hydroperoxides
which are converted to reactive aldehydes eventually causing damage in the amino acids of the
protein. Cu (II) can bind to His residues in apo B-100 in LDL117and initiate oxidation of the
LDL. Other studies also indicated that Trp residue can act as a binding site for Cu (II) ions. Trp
residues have a tight-binding spot as well as a weak binding spot. However, the position of those
Trp residues in apo B-100 was not discussed in detail.117,

118

It seems therefore plausible that

mechanism of Cu (II) mediated oxidations of apo B-100 vary significantly from hydroxyl radical
mediated oxidation of LDL. Hydroxyl radical can react rapidly with the amino acids that are
radical accessible and damage the protein directly. On the other hand in Cu (II) mediated
oxidations predominantly secondary lipid oxidation products such as aldehydes are generated
and subsequently modify amino acids (Lys and His).
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Scheme 3.11 Lysine (Lys) reacts with α, β-unsaturated aldehydes (acrolein and 4-HNE) to yield various
products including MP-Lys (+76 Da), FDP-Lys (+94 Da) and 2-petylpyrrole-Lys (+138 Da and +120 Da).
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3.4.3. Peroxynitrite mediated oxidation of apo B-100 in LDL
Peroxynitrite is not a free radical. The unpaired electron of nitric oxide is paired with the
unpaired electron of superoxide to produce a covalent bond. Nonetheless it is highly reactive.
Peroxynitrite leaves a specific stable footprint on side chains of amino acids. It directly modifies
three different amino acids: cysteine, methionine and tryptophan.56,

59

Oxidation was also

observed for other aromatic amino acids such as tyrosine, phenylalanine and histidine through
secondary mechanisms (involving carbonate and hydroxyl radical). Peroxynitrite mediated
cysteine oxidation in albumin was previously reported with a second order rate constant70 on the
order of 103 M-1s-1. Cysteine has reactive thiol groups which were converted to the
corresponding sulfonic acids (+48 Da). Methionine contains thiol groups and is fairly susceptible
to oxidation to yield methionine sulfoxide (+16 Da). Tryptophan residues are oxidized to form
nitrotryptophan69,

119, 120

(Scheme 3.13) and N-formylkynurenine (+32 Da) (Scheme 3.8).

Interestingly tryptophan can be nitrated (+45 Da) (Scheme 3.13) as well as hydroxylated (+16
Da) at the same time.121
O

O
-O

ONOO
HO

HN

O

N

HO

HN

Scheme 3.12 3-Nitrotyrosine (+45 Da) formation on peptides from peroxynitrite reaction on tyrosine side
chain.

Tyrosine nitration (+45 Da)122, 123 (Scheme 3.12) in proteins requires special discussion.
As nitric oxide cannot directly promote the nitration reactions in physiological systems,
peroxynitrite appears to be the sole initiator for nitration. It has become apparent that other
mechanisms of protein nitration exist. For example hemeperoxidase, hydrogen peroxide and
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nitrite can cause nitration of tyrosine.68, 124, 125 However, it should be noted that protein tyrosine
nitration could happen following this pathway only if the enzyme is immediately accessible to
oxygen radical and nitric oxide radical. Direct oxidation by nitrite radical was minor particularly
since low oxygen tension in tissues made the conversion of nitric oxide radical to nitrite radical a
slow process and also nitrite radical will preferentially attack the thiols due to their higher
reactivity. Alvarez et. al. provided interesting evidence on oxidation of Cys using human serum
albumin and peroxynitrite.126 In the presence of carbon dioxide, cysteine oxidation decreased and
an increase in tyrosine nitration was observed.
H
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N
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N
O
NH

NH

O

O

Scheme 3.13 Tryptophan nitration by peroxynitrite (+45 Da), 4, 5, 6-nitrotryptophan are all possible.

Therefore nitration of biomolecules indicates the involvement of nitric oxide radical
derived oxidant species during oxidative damage. Consequently, peroxynitrite plays a central
part in protein tyrosine nitration.
Since hydroxyl radical generation from peroxynitrite is not unlikely though less probable,
markers for hydroxyl radical mediated oxidation products of Tyr and Phe were observed in
peroxynitrite mediated oxidation pathways.121
Peroxynitrite mediated oxidation induces changes in the amino acid residue and primary
structure of the proteins by changing their chemical environment. It oxidizes LDL and initiates
unfolding in LDL protein.121

68

3.4.4. Apo B-100 oxidation with hypochlorus acid
LDL oxidation with hypochlorus acid was observed both in vitro127, 128 and in vivo.31-33,
129

In the late 1990’s chlorotyrosine (+35 Da) (Scheme 3.14) was proved as one of the specific

markers for HOCl mediated oxidation in apo B-100. By a stable isotope dilution gas
chromatographic-mass spectrometric method, high levels of 3-chlorotyrosine deposition in
atherosclerotic plaque was measured.27, 32 3,5-Dichlorotyrosine formation was also observed in
apo A-I when treated with high concentrations of HOCl.130 Lysine chloramines were deemed to
be unstable and difficult to detect in protein samples due to cross-linking and carbonyl
formation. By studying model peptides related to the apo A-I sequence, Bergt et. al. was able to
detect monochloramine (+34 Da) and dichloramine (+68 Da)130 in Lys residues. Most
interestingly, these peptides did not have any other reactive amino acids besides Lys and Tyr,
indicating secondary pathways originated from chloramine hydrolysis.78, 131 Chloramines on Lys
residues hydrolyze to form aldehydes (aminoadipic semialdehyde) which were previously
detected by carbonyl method. Methionine is easily oxidizable and could form methionine
sulfonic acid (+ 16 Da) (Scheme 3.15). Reactive thiol of cystein goes to corresponding sulfonic
acids (+48 Da)78 (Scheme 3.16). Upon oxidation with HOCl, tryptophan hydroxylation (+16 Da)
occurs in the indole ring (Scheme 3.17). Also, through intramolecular radical reaction Trp can
yield the ring breaking products kynurenine (+4 Da) and N-formylkynurenine (+32 Da) (Scheme
3.8). Histidine forms an unstable chloramine on the side chain which can readily be donated to
other neighboring amino acids (such as Lys) to regenerate parent His residue.78,
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Guanidine

moiety of Arg is susceptible to chloramine (+34 Da) formation upon incubation with
hypochlorus acid. The stability of this chloramine on Arg residues are not extensively studied or
known. Unfortunately, only chlorotyrosine appears to be a definitive marker of hypochlorus acid

69

mediated oxidations. Other products were unable to provide specific indication of HOCl
oxidation and could be originated from other oxidants.132
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Scheme 3.14 Reactions of Tyrosine and hypochlorus acid to form of 3-chlorotyrosine (+34 Da) and 3, 5dichlorotyrosine (+68 Da) in peptides and proteins.
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Scheme 3.15 Methionine oxidation to methionine sulfoxide (+16 Da) is most common and can happen even
with ambient oxygen.
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Scheme 3.16 Oxidation of cystein (Cys) to cysteine sulfonic acid (+48 Da) in presence of HOCl. This product is
also observed previously with peroxynitrite treated samples.

Scheme 3.17 Oxidation of Tryptophan (Trp) to 2-Oxindolic form by HOCl.
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3.5. Atherosclerosis and oxidized LDL (ox-LDL)
Atherosclerosis is a complex cardiovascular disorder which was correlated with high
levels ox-LDL formation. Although controversy exists on whether circulating plasma ox-LDL
(detected in low concentration in blood) is responsible for atherosclerosis, recent prospective
reports were more inclined towards a positive correlation.25, 133, 134 Specific oxidized epitopes on
ox-LDL in blood may trigger atherosclerosis and other manifestations.40 LDL can permeate
through vascular endothelial cells and smooth muscle cells. During this infiltration to arterial
intima, LDL can be oxidized by several reactive oxygen species (Figure 3.6). Ox-LDL was
removed by immunoglobulin M (IgM) antibodies in the form of immune complex.135 However,
some of the ox-LDL particle can escape this removal pathway. The escaped ox-LDL particles
will be taken up by macrophages through scavenger receptor CD-36.136-140 Inclusion of ox-LDL
inside the macrophage could initiate lipid laden foam cell formation. Several signaling pathways
such as pro-inflammatory cytokines, TNF-α and interleukins141 become activated. Foam cells
release more ROS and myeloperoxidase (MPO) which could be responsible for generating more
ox-LDL.91 Foam cells can also bind to T-cells circulating in blood40, 142 (Figure 3.6). Foam cells
adhere strongly to endothelial cells and initiate fatty streak formation and thereby induce
inelasticity in the arterial wall. This is major early event of plaque formation.
Interaction of apo B-100 with arterial proteoglycans increases the retention of the LDL in
the arterial intima.94, 96, 102, 103, 105, 143 Proteoglycan obtained from atherosclerotic patients showed
higher uptake of LDL than normal patients. Also ox-LDL particles are cytotoxic and induce cell
apoptosis.55, 144, 145
Ox-LDL formation in the sub-endothelial cells can facilitate atherogenic progression.
Oxidized LDL limits the biological activity of the endothelium derived nitric oxide.40 It was
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apparent that this phenomenon increases entry of the inflammatory cells into the arterial wall. In
addition it was discovered that ox-LDL stimulate macrophage expression of peroxisome
proliferator activated receptor-γ (PPAR-γ). Scavenger receptor (CD36) expression and
expression of pro-inflammatory genes were shown to be altered by macrophage expression of
PPAR-γ.146
Several studies described peroxynitrite mediated oxidation of LDL as an important event
in atherosclerotic plaque formation. Leeuwenbergh et. al. emphasized enzyme involvement
(MPO) and formation of tyrosyl radical in oxidation of LDL.68 3-nitrotyrosine (3-NT) was
detected immunocytochemially in macrophages, foam cells and vascular smooth cells147.
Interestingly, 3-NT accumulated even in the presence of extracellular superoxide dismutase
(SOD), indicating that the formation of peroxynitrite can outcompete superoxide dismutation.148
Controversial data were observed on the level of 3-NT in LDL obtained from human plasma and
arterial intima.68,

149

Vascular hemodynamics could play a crucial role in accumulating 3-NT

through peroxynitrite mediated pathways. Immunohistostaining of coronary arterial bifurcations
reveal the importance of fluid shear stress on peroxynitrite formation and accumulation in the
arterial intima.150
3-Chlorotyrosine is a known marker of atherogenic condition.27, 31, 32, 132 An increase in
scavenger receptor CD36 uptake of HOCl treated ox-LDL was reported indicating high
probability of lipid laden foam cell formation.151,

152

Chloramine formation on Arg residues

inhibited endothelial cell nitric oxide synthase activity. Therefore vascular endothelial nitric
oxide production mechanism was altered which may attribute to endothelial dysfunction.153
Antioxidants play an obvious role in inhibiting the progression of atherogenesis.
Ascorbate154,

155

, urate and α-Tocopherol reduce LDL oxidation. However, α-tocopherol is
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associated with LDL and played the most important role in preventing LDL oxidation156 in
circulation as well as in sub-intima.
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Figure 3.6 Oxidized LDL formation in the endothelial cells and arterial intima. Ox-LDL was taken up by
macrophages through scavenger receptor CD36. Lipid laden foam cell formation was depicted in the figure
which showed high adhesion properties for binding to the arterial wall.

3.6. Targeted proteomics with LC-MS/MS based methodologies
Evolution of the versatile mass spectrometric instrumentation in post-genomic era
revealed new horizons in protein mass spectrometry. Marc Wilkins coined the term “proteomics”
in 1994 while working with a 2D-Gel based protein samples following a notion that all proteins
were expressed from the genome.157 In biological studies, however, the concept of proteomics
was expanded to a new level in order to answer more critical and demanding questions.
Proteomics is no longer confined in protein sequencing and profiling but also used to study
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protein post translational modifications and protein-protein interactions in cells and tissues.158-160
Discovery and development in the field of protein and peptide ionization techniques in mass
spectrometry helped the biologists and chemists to perform complex protein/peptide mixture
analysis.
Two “soft” ionization techniques were extensively used in protein mass spectrometry.
Matrix assisted laser desorption ionization (MALDI)161 was extensively used in identifying
proteins. In this method the samples are mixed with a specific matrix (organic compounds such
as sinapinic acid or dihydroxybenzoic acid). A laser beam transfers energy to the matrix which in
turn ionizes the peptides or the proteins.
Electrospray ionization161, 162 is also a soft ionization technique where a high electrical
potential is applied to the analyte solution such that the analyte molecule(s) can form charged
droplets (Figure 3.7). Driven by a potential gradient as well as a pressure gradient along the ion
passage, the droplets follow a desolvation process leading to downsizing of the droplets.
Constant evaporation continues until fully desolvated ions are formed.
In one instrument design, the ions then enter into the linear ion trap (Figure 3.7) (in our
case, a Thermo Finnigan LTQ-ion trap instrument coupled with HPLC). By a suitable
combination of constant direct current (DC), radio frequency (RF) and oscillating alternative
current (AC) in the ion traps, ions can be stabilized (precursor ion isolation), fragmented
(collision induced dissociation) and detected. Helium is used as a collision gas in the traps for
damping and cooling of ions (detailed discussion in chapter 4).
Liquid chromatography adds physical separation capabilities in LC-MS/MS based
approach. In a complex mixture of proteins and peptides the separation before the mass
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spectrometric detection increases the sensitivity and specificity of the detection. Overall this
methodology provides a robust and a powerful detection in protein sequencing.

3.6.1. Database search
Database search is by far the most crucial parameter in identification of post translational
modifications in proteins. Mass spectrometric data for biomacromolecules are complex. Various
algorithms exist to identify the peptides from complex biological mixtures. A full length cDNA
sequence of apo B-100 (accession # P04114) was employed in our database search using
SEQUEST algorithm.
When a sequence is added to a database, the software theoretically cleaves the sequence
to peptides (precursor ions). The precursor ions are fragmented to its corresponding B-ions
(charge stays with amine terminal) and Y-ions (charge stays with carboxylic acid terminal). In
mass spectrometric data both precursor ion and corresponding B- & Y-ions are observed. The
observed tandem mass spectra were matched with the theoretical B- and Y- ions.

∆C n =

Primary Xcorr - Secondary Xcorr
Primary Xcorr

Equation 3.8

Where, Primary Xcorr is the best match and secondary Xcorr is the second best match.
The match between the theoretical and experimental spectra generates a score known as
X-correlation score which defines goodness of fit. ∆Cn score on the other hand indicates the
specificity of the match and mathematically defined as Equation 3.8. Although there is a certain
degree of uncertainty involved in the database search method, improvements are on their way.163
Based on the Xcorr, ∆Cn value, identification of peptide was initially filtered. The identified
peptides that passed the filter were further verified manually by matching the spectra and
theoretically calculating the masses.
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Figure 3.7 Schematic representation of liquid chromatography (LC) – mass spectrometry (MS) setup for analysis of peptide mixture in positive ion
mode.
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3.6.2. Protein surface mapping by LC-MS/MS
Protein footprinting164-168 has become popular in the last decade. By using laser flash
photolysis method hydroxyl radical can be generated. Generated hydroxyl radical can react with
amino acid residues in protein and leave a stable footprint on them. Kinetics of amino acid side
chain reactions were well documented.106 These stable footprints could be determined by LC-MS
based methodologies. Aye et. al. tuned the laser flash photolysis method and identified several
surface accessible oxidation sites in model protein ubiquitin and apomyoglobin.164 Hambly and
co-workers worked on laser flash photochemical oxidation of proteins (FPOP) and identified
important structural characteristics of apo and holo myoglobin.165,

166

Sharp et. al. reported

solvent accessible surface mapping on apomyoglobin, lysozyme and β-lactoglobulin A.169,

170

Hydroxyl radical reactivity towards the side chain of the amino acids depends on the
accessibility of the side chain and reactivity of the side chain residue.171 Bridgewater and coworkers studied amino acid-metal binding interactions through metal catalyzed oxidation and
mass spectrometry.154,

172, 173

Shcherbakova et. al. proved the usefulness of using inexpensive

Fenton method for generating hydroxyl radical during the footprinting of protein, DNA and
RNA.167

3.6.3. LC-MS/MS studies on LDL
Considerable attention was focused on HDL cholesterol and apo A-I oxidation8, 9, 81, 130,
while studies on apo B-100 in LDL was fairly limited.115, 121 Ample evidence indicated strong
positive correlation between oxidation of apo B-100 and atherosclerosis.31, 33, 36, 68, 150, 174, 175 Free
radical mediated oxidations in apo B-100 brings about non-specific heterogeneous changes in the
protein. Heinecke and co-workers have studied both HDL and LDL proteins for specific
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footprints by employing various analytical techniques.31-33, 35, 77, 130, 176 Leeuwenburgh et. al. used
advanced GC/MS methodologies to identify oxidation products of apo B-100.68
A great deal of emphasis was exhausted to understand Cu (II) mediated oxidations of
LDL. Moreover, as discussed earlier Cu (II) can bind to amino acid residues such as His and Trp.
Therefore, it will initiate oxidation in the protein by lipid mediated pathways. Previously, Yang

et. al. identified Cu (II) mediated oxidation of Trp in apo B-100 with HPLC followed by a MS
methodology which was robust but required a tedious complicated follow-up work.177 Obama et.

al. identified Cu (II) mediated oxidation sites in apo B-100. In in vitro experiments with apo B100, HNE and acrolein, several different binding sites were identified by LC-MS/MS based
methodologies.115Oxidation product of Trp (NFK) was quantitatively measured by HPLC
method after apo B-100 was oxidized in LDL.178
Butt et. al. detected nitrated proteins by 2D-gel and mass spectrometric approach.179
Recently, Hamilton and co-workers reported some oxidized residues in apo B-100 during LDL
incubation with peroxynitrite. Extensive circular dichorism and LC-MS/MS methodology were
used to identify the oxidized residues121on apo B-100.
Effect of hypochlorus acid on LDL was studied extensively by Mike Davies’s group.75, 79,
82, 131, 180, 181

Several interesting mechanistic and kinetic work on hypochlorus acid and amino

acids, peptides and proteins were published over last fifteen years.75,

78, 82, 180

However, free

radical based footprinting combined with proteomics would render new insights in apo B-100
oxidation.

3.7. Total hydroxyl radical quantitation
The flux of hydroxyl radical and hydrogen peroxide formed in a cellular system varies
significantly depending on the stress condition. Also the flux of H2O2 can be generated
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periodically in the cells. Chance and co-workers quantitated concentration of hydrogen peroxide

in vivo which is on the order of 10-7 to 10-8 M.182 In H2O2 induced cell apoptosis studies, Antunes
et. al. used 10-3 to 10-5 M H2O2 which is two to five orders of magnitude higher than the cellular
concentration.183 Complex mechanisms drive hydroxyl radical mediated oxidation of proteins in
cells. Kinetic studies involving hydroxyl radical in cells and tissues yield complicated and
interfering results. However, total hydroxyl radical formed by Fe (II) and H2O2 (Fenton method)
can be quantitated by a probe based approach. Benzoic acid can efficiently trap hydroxyl radical
formed to yield hydroxybenzoic acids (o-, m-, p-hydroxybenzoic acid).
High performance liquid chromatography (HPLC) (Figure 3.8) was extensively used to
identify and quantitate hydroxybenzoic acids.184, 185 If benzoic acid concentration is considerably
high compared to the hydroxyl radical formed, it would be possible to trap all of the hydroxyl
formed by the Fenton system. This hypothesis however is good only if other scavengers were
present in low quantities and/or show lower radical trapping efficiency. Zhou et. al. showed an
effective trapping efficiency of benzoic acid to hydroxyl radical in aqueous samples.185 Lindsey

et. al. provided an improved analytical methodology to detect low concentration of p-HBA in
hydroxyl radical trapping experiment with benzoic acid.184 Therefore effective hydroxyl radical
concentrations for LDL exposure were calculated in this study by benzoic acid experiments.
Hydroxyl radical formed from low micromolar to low milimolar H2O2 was quantitated by
benzoic acid method (for details please see chapter 4).
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3.8. Analysis of natural variants
3.8.1. What are natural variants?
Natural variants are defined as variations in the amino acids in a reported sequence
(canonical sequence) in the sequence database. Canonical sequence contains most common
polymorphs or the most conserved orthologus genes. Various types of natural variants exist in
proteins. Single amino acid polymorphisms appear due to a single nucleotide change at the
codon level. Disease associated mutations in amino acids are also possible in the sequence.
During RNA editing events the protein primary structure changes (changes in the amino acid
sequence).

3.8.2. Mass spectrometry database search on natural variants
Mass spectrometry was not fully exploited in determining natural variants in low density
lipoproteins. However, various efforts were made to identify natural variants in hemoglobin by
using mass spectrometric method.186-189
Fifty one natural variants are reported for apo B-100 on Swissprot over last twenty four
years.16 A novel database search method was employed in this studt to identify some of the
reported natural variants in apo B-100. By slightly tweaking the database search, rapid
identification of reported natural variants was possible. By simply analyzing tandem mass
spectra it is not possible to differentiate the natural variants leucine (Leu) and isoleucine (Ile)
(m/z: 113). However, these amino acids are translated from different cDNA codons. In database
search, our endeavor was to include those natural variants which were reported by other methods
to develop a rapid screening technique for clinical samples. This unique methodology could
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expand the horizon of mass spectrometry to determine amino acid variants in protein clinical
samples.
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Chapter 4.
Mapping oxidations of apo B-100 in human low density lipoprotein
by LC-MS/MS
4.1. Abstract
Human low density lipoprotein (LDL) is a major cholesterol carrier in blood. Elevated
concentration of low density lipoprotein, especially when oxidized, is a risk factor for
atherosclerosis and other cardiac inflammatory diseases. Past research has connected free radical
initiated oxidations of LDL with the formation of atherosclerotic lesions and plaque in the
arterial wall. The role of the LDL protein in the associated diseases is still poorly understood,
partially due to lack of structural information. In this study, LDL was oxidized by hydroxyl
radical. The oxidized protein was then delipidated and subjected to trypsin digestion. Peptides
derived from trypsin digestion were analyzed by LC-MS/MS. Identification of modified peptide
sequences was achieved by database search against apo B-100 protein sequences using the
SEQUEST algorithm. At different hydroxyl radical concentrations, oxidation products of
tyrosine, tryptophan, phenylalanine, proline and lysine were identified. Oxidized amino acid
residues are likely located on the exterior of the LDL particle in contact with the aqueous
environment or directly bound to the free radical permeable lipid layer. These modifications
provided insight for understanding the native conformation of apo B-100 in LDL particles. The
presence of some natural variants at the protein level was also confirmed in our study.

Keywords: LDL, hydroxyl radical, LC-MS/MS, oxidative mapping, natural variants.
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4.2. Introduction
Low density lipoprotein (LDL) acts as a major cholesterol carrier in the human body.
LDL consists of a lipid core of triacyl glycerol and cholesteryl ester and an outer layer of
phospholipids with free cholesterol and apo B-100 (Figure 3.3). Apo B-100 was reported as a
single monomeric protein consisting of 4563 amino acid residues1 encircling the LDL molecule.
This protein plays an intricate role in LDL receptor binding.2 Oxidative modification of LDL
(ox-LDL) is considered as a major risk factor since it plays a critical role in the pathogenesis of
atherosclerosis.3-7 During oxidative stress various radicals are generated in the human body
which can induce the oxidation of LDL. Thereafter ox-LDL can be taken up by macrophages
through scavenger receptors in smooth muscle cells, which lead to foam cell formation.7, 8 Foam
cells interact with pro-inflammatory cytokines and enhance the adhesion of ox-LDL to the
arterial wall, a major early event of atherosclerotic plaque formation (Figure 3.4). In addition, it
was also reported that interaction of aberrant apo B-100 with proteoglycans induces the
generation of atherosclerotic plaques.9, 10
The primary source of free radical in the human body is superoxide.11,

12

By various

physiological mechanisms, less reactive superoxide is converted to reactive peroxyl, alkoxyl and
hydroxyl radicals. The last of this list is known to be highly reactive and cause non-specific,
extensive damage to lipids and proteins.13 In vitro studies have shown the generation of hydroxyl
radical by the well established mechanism of Fenton chemistry.14, 15 The nature of oxidation of
apo B-100 by hydroxyl radical and its implications in atherosclerosis4,

7

is still poorly

understood.16 Finding the oxidation sites for apo B-100 is relevant and important for its
structure-function relationship. Several attempts were made to elucidate the structure of apo B100 by 3-D modeling and a pentapartite domain arrangement was proposed.17, 18 However, these
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studies have some uncertainties involved, making the protein structure predictions speculative.
Oxidation of LDL can occur by various pathways. One group of researchers strongly believes
that lipid peroxides (oxidation products of LDL lipids) are involved in the atherosclerotic plaque
formation8,

19

, while other researchers reported oxidation of apo B-100 (LDL protein) as the

important step in atherogenesis.7, 20-22 There are two reported pathways (Table 4.2) for hydroxyl
radical mediated apo B-100 oxidation in LDL. The direct oxidation pathway of apo B-100
involves the oxidation of amino acid residue by extensive cross-linking, peptide bond cleavage
and also oxidation of side chains.4, 13, 15, 21, 23, 24 The hydrophobic amino acid residues such as
Phe, Tyr, and Trp undergo simple hydroxylation reactions. This pathway prevails when the
radical generation site is in close proximity to the apo B-100. The indirect oxidation pathway of
apo B-100 involves indirect oxidation through an intermediate lipid reactive species. Several
lipid peroxidation products such as 4-hydroxynonenal (HNE) and acrolein can form. These
molecules contain unsaturated aldehydes and are highly reactive electrophiles which can react
with histidine, lysine and cysteine residues to form Michael and Schiff base adducts. The εamino group of lysine specifically reacts with acrolein to form Nε-(3-formyl-3,4dehydropiperidino)lysine (FDP-Lys) and Nε-(3-methylpyridinium)lysine (MP-Lys).25,

26

The ε-

amino group of lysine also reacts with HNE to yield a HNE-Lys Schiff base adduct which
readily loses water to yield 2-pentylpyrrole-Lys adduct.27 These two processes result in mass
increases of 138 Da (Lys+138) and 120 Da (Lys+120) in lysine residues. Histidine also forms
adducts such as HNE-His.6, 25, 26, 28 All of these modified amino acid residues are listed in (Table
4.1). As mentioned earlier, hydroxyl radical mediated oxidation of apo B-100 in LDL can be of
two distinct types, namely direct oxidation (hydroxyl radical must have direct access to the
amino acid residue of apo B-100) and oxidation via lipid intermediates (hydroxyl radical
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oxidizes the lipid and the reactive lipid species subsequently reacts with the protein). During
oxidative modification of LDL, the variety and magnitude of modifications can be substantially
diverse for each LDL particle. Uchida, et al. explored protein modifications in ox-LDL by apo
B-100 hydrolysis and used antibodies to verify formation of HNE and acrolein adducts. Those
studies, however, did not elucidate the oxidation sites of apo B-100.25, 26
Table 4.1 List of oxidatively modified amino acids (hydroxyl radical mediated) previously reported in
literature.

Major Amino acid Oxidation Products Reported in Literature
Amino Acid

Direct Oxidation

Oxidation via Lipid Pathway

Dihydroxyphenylalanine12-14, 20 (DOPA)
Tyrosine

N.D.
(Y+16), Dityrosine

Phenylalanine

o-/m-tyrosine12, 13, 20

N.D.

5-/7-Hydroxytryptophan, Kynurenine, NN.D.

Tryptophan
formylkynurenine

12-14, 20

Michael & Schiff Base adduct
Histidine

2-Oxohistidine12-14, 20
formation14, 24-26
Michael & Schiff Base adduct

Lysine

Aminoadipic semialdehyde

22, 23, 52

formation14, 24-26
Arginine

Glutamic semialdehyde22, 23, 52

N.D.

Proline

Glutamic semialdehyde22, 23, 52

N.D.

N.D. Not determined
Mass spectrometry (MS) is one of the most powerful tools to identify post translational
modifications of proteins. LC-MS/MS based studies on proteins were demonstrated previously as
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powerful techniques in determining the stable oxidative products in proteins.22, 29-32 Research has
been done on oxidative modifications of apolipoprotein A-I (30 KDa protein) in high density
lipoprotein (HDL) by Heinecke and coworkers.33,

34

Bolgar, et al. identified HNE adducts of

histidine by MS/MS for the first time.35 Several different approaches were taken by various
researchers to follow the oxidation pattern of apo B-100 in LDL. Karlsson, et al. 36 used 2D-CE
and MS analysis, and Heller, et al.

37

utilized SDS-PAGE followed by MS analysis. However,

these studies were focused on small apolipoproteins. The determination of oxidation sites is
complicated since the modifications are non-specific in nature. Recently Obama, et al. identified
some oxidized amino acid residues using polyvinylidene (PVDF) membranes

22

by incubating

LDL with Cu2+ ion. Obama’s method showed improved efficiency in removing the lipid from
apo B-100 for LC-MS/MS analysis. Also, in PVDF membranes, digestion with trypsin showed
greater peptide recovery. The current study focused on oxidative mapping of amino acid residues
including those with hydrophobic side chains such as Phe, Pro, and Trp. Several other amino
acid residues were found to be oxidized with variable concentrations of hydrogen peroxide
mixed with Fe (II).
Amino acid residues in the human apo B-100 sequence sometimes differ from the
reported sequence (P04114).1 These changes in the amino acids are known as natural variants.
Apo B-100 has been shown to contain several natural variants in its sequence.38-47 Often times
these variants were attributed to polymorphism and/or disease.41 Fifty-one natural variants were
reported so far in the cDNA or expressed sequence tag (EST) of apo B-100.1 In addition to
oxidative mapping, the presence of some reported natural variants in the LDL was revealed in
this study from direct protein analysis via LC-MS/MS experiments.
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4.3. Materials and methods
Human low density lipoprotein (LDL) was purchased from VWR chemicals. Each batch
of LDL was acquired from a single, healthy human subject. LDL was stored with 150 mM
ethylenediaminetetraacetic acid (EDTA) and was kept refrigerated (4 °C). Iron sulfate (FeSO4·7
H2O), disodium ethylenediaminetetraacetic acid (Na2EDTA), and all solvents were purchased
from VWR. Micro-dialysis tubes and floats were also purchased from VWR. High purity (99%)
4-hydroxybenzoic acid (4-HBA), ammonium bicarbonate (ABC), dithiothritol (DTT) and
iodoacetamide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Trypsin was
purchased from Promega (Madison, WI, USA). In all experiments, purified water was obtained
by deionization and UV irradiation.

4.3.1. Quantitation of hydroxyl radical
High performance liquid chromatography (HPLC) was used to quantify the total amount
of hydroxyl radical formed. In this approach, a high loading of benzoic acid (10 mM) was added
in order to scavenge all radical that was formed (detailed method described elsewhere 48, 49). The
reaction between benzoic acid and hydroxyl radical has a known second order rate constant and
forms a characteristic product, 4-HBA. The amount of 4-HBA formed during the reaction
between hydrogen peroxide and Fe2+ was determined. In short, 400 µL of 50 mM FeSO4 (final
concentration 1 mM), 400 µL of 50 mM Na2EDTA (final concentration 1 mM), and different
concentrations of hydrogen peroxide (final concentrations 9 µM, 90 µM, 900 µM, 4500 µM and
9000 µM) were added to 20 mL of 10 mM benzoic acid (aq). In these experiments hydrogen
peroxide was added as a bolus addition. The reaction was carried out for 25 minutes and was
quenched by addition of 200 µL of methanol and acidified with 2 drops of concentrated HCl. The
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sample was loaded onto a 1.5 mL loop. An Alltech 15 cm C18 (4.6 mm I.D., and ODS 5 µm)
column was used for separation of 4-HBA from the reaction mixture with detection by UV
absorbance at 234 nm. The elution gradient was water acidified to pH ~ 2.5 with trifluoroacetic
acid (A) and acetonitrile (B): 0-3 min 10% B; 3-12 min linearly to 44% B; 12-13 min linear to
100% B. The analytes were pre-concentrated on column in the first 3 minutes, and then were
eluted by increasing the solvent strength. A calibration curve was formulated from peak area
under the HPLC trace daily (R2>0.99) with 4-HBA standards (at least 2 replicates) at
concentrations of 0.5 µM, 10 µM and 25 µM. Oxidized benzoic acid samples were injected using
at least 3 replicates for each concentration of hydrogen peroxide exposure. Peak area
corresponding to 4-HBA in the reaction mixture was compared to that of the standards used in
calibration (Figure 4.1).

4.3.2. Oxidative modification of LDL
Ten microliters of LDL (5.3 mg/ml) was diluted to 100 µL with purified water to yield a
concentration of 0.53 µg/µL of apo B-100. Eight samples were placed in separate micro-dialysis
tubes (MW cut off 3500 Da) and were then dialyzed against 500 mL ABC buffer (pH = 7.4, 25
mM) for 24 hrs at 4 °C. The dialyzed LDL samples were collected and placed in small microcentrifuge tubes. Each exposure was carried out in duplicate. Hydroxyl radical was generated by
adding 2 µL of 50 mM Na2EDTA, 2 µL of 50 mM FeSO4·7H2O (aq) and 6 µL of aqueous
hydrogen peroxide (0.15 mM, 1.5 mM or 15 mM). Immediately after addition and mixing, the
concentrations of the added hydrogen peroxide were 9 µM, 90 µM or 900 µM. The reaction was
carried out for 25 minutes at room temp in an Eppendorf Thermomixer R in the dark with
constant shaking at 800 rpm. Control experiments with no peroxide addition were carried out at
about the same time when hydrogen peroxide exposures were performed. Immediately after the
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reaction period the treated samples were placed in micro-dialysis tubes for dialysis against
acetone (24 hrs at 4 °C) to remove lipids and other hydrophobic molecules. Then the treated
samples were further dialyzed against methanol:aqueous 50 mM ammonium bicarbonate (3:2)
for 24 hrs at 4 °C. Samples were collected in plastic tubes and were placed in boiling water for 510 minutes for partial denaturation of the protein. Thirty molar excess dithiothritol (DTT) was
added and samples were incubated for 30 minutes at 37 °C to cleave the disulfide linkages. Next,
30 molar excess iodoacetamide was added and let react for 90 minutes at 37 °C for alkylation of
the cysteinyl residues. Tryptic digestion was carried out overnight following previous methods.50,
51

The tryptic peptides were quenched with liquid nitrogen, vacuum dried, and reconstituted in

5% aqueous formic acid with 5% acetonitrile for LC-MS/MS analysis. Samples were stored at 80 °C until analysis.

4.3.3. LC-MS/MS analysis of apo B-100
The peptide mixture obtained from the procedure noted above (maximum amount
equivalent to 3 µg protein) was first loaded onto a reversed-phase trap column, and then washed
with 3% acetonitrile and 0.1% formic acid (aq) to desalt the sample. After the wash/desalt step,
the trap column was switched into a gradient flow (60 minutes, water with 3% acetonitrile and
0.1% formic acid at the beginning and 65% acetonitrile with 0.1% formic acid at the end) to
elute peptides to a C18 analytical column before introduction into a linear trapping quadrupole
(LTQ) mass spectrometer.

4.3.4. MS setup
Mass spectrometry analyses were performed on a LTQ mass spectrometer (Thermo
Electron, San Jose, CA) equipped with a nano-flow (200-500 nL/min) electrospray source. The
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peptides were ionized via electrospray and recorded in a full scan mass spectrum in a positive ion
mode. For each full MS scan, the top 3 most intense peptide precursor ions were selected and
fragmented via collision induced dissociation (CID). Low pressure helium was employed as
damping (for ion storage and isolation) and collision (fragmentation of activated ions) gas. The
instrument was operated in a highly automated data dependent acquisition mode.

4.3.5. Database search
The database search was performed on an in-house search engine (Bioworks 3.3, Thermo
Electron) using the SEQUEST algorithm. Apo-B sequences (P04114) and seven other sequences
that include reported natural variants were compiled in a small database for searching (Table
4.2). Peptides with MW of 600-3500 Da were chosen for identification. All modifications were
defined as differential (unmodified peptides were also searched) and are listed in (Table 4.2).
Trypsin was selected as the proteolytic enzyme, and the database search included identification
of one missed cleavage of Lys or Arg. An Xcorr score was generated from the matching of
experimental spectra to the theoretical spectra of apo B-100 peptides. A charge state-Xcorr score
filter was applied to all MS/MS spectra. Singly charged peptides with Xcorr score less than 2,
doubly charged peptides with Xcorr score less than 2.5, and triply charged peptides with Xcorr
score less than 3.0 were considered as false positives and removed from the final report.

4.4. Results
Reaction of hydroxyl radical in cells follows complicated pathways making it difficult to
understand the underlying mechanisms and kinetics. The total amount of hydroxyl radical
reacted can however be calculated. This information was helpful to determine the total hydroxyl
radical generated during hydrogen peroxide incubation with LDL. We have quantified the total
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amount of hydroxyl radical

48, 49

that was formed after a bolus addition of hydrogen peroxide to

aqueous iron in the presence of EDTA.

4.4.1. Total hydroxyl radical quantitation using benzoic acid with HPLC
LDL was exposed to hydroxyl radical at three different doses obtained by varying
hydrogen peroxide concentration in the oxidation step. Quantitation of the total amount of
hydroxyl radical formed at each of these peroxide/hydroxyl radical doses was carried out by
reaction with excess benzoic acid. Hydroxyl radical reaction with benzoic acid yields several
products, including 2-hydroxybenzoic acid, 3-hydroxybenzoic acid and 4-hydroxybenzoic acid.
4-Hydroxybenzoic acid makes up approximately 1/6 of the total products formed.48,

49

Consequently, the total amount of benzoic acid that reacted with hydroxyl radical can be
calculated by measuring only the amount of 4-HBA formed and then multiplying this amount by
a factor of 6.48 The total amounts of hydroxyl radical formed after 25 minutes of reaction at
different peroxide concentrations were calculated to be 0.78 ± 0.03 micromoles, 1.7 ± 0.3
micromoles and 3.1 ± 0.04 micromoles for 9 µM, 90 µM, and 900 µM H2O2 doses, respectively
(95% confidence limits). These data are presented in Figure 4.1. The total radical formed was
also quantitated for 4.5 mM and 9 mM hydrogen peroxide concentrations, but the total amount of
hydroxyl radical produced did not increase beyond that observed for 900 µM peroxide (Figure
4.1).
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Figure 4.1 Total hydroxyl radical produced by adding different hydrogen peroxide concentrations to 10 mM benzoic acid in the presence of 1 mM
FeSO4.7H2O and 1 mM Na2EDTA in water.
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4.4.2. Sequence coverage
As mentioned earlier tryptic peptides were searched against a full length cDNA sequence
of apo B-100 protein (P04114) listed in the IPI-human database1 using the SEQUEST algorithm.
For large proteins such as apo B-100 it is difficult to get high sequence coverage via LC-MS/MS
analyses of the peptides derived from trypsin digestion.19, 23 We achieved (48 ± 1) % (2 samples)
sequence coverage from untreated LDL samples (Figure 4.2). For the sample with no peroxide
added and for the LDL treated with 9 µM H2O2 (both with 1 mM Fe2+ and 1 mM Na2EDTA) the
recovery was (45 ± 2) %. These results are comparable to earlier work.22 With high
concentrations of H2O2 (90 µM and 900 µM), however, our recovery decreased to (33 ± 2) % and
(26 ± 3) %, respectively. The decrease in the sequence coverage is plausible since high hydroxyl
radical concentrations would result in substantial protein degradation including lysine and
arginine modifications and additional unknown modifications of amino acid residues. Such
highly degraded peptides would be unlikely to match a database search based on the unmodified
protein sequence. A figure (Figure 4.2) indicating the sequence coverage for all samples is
presented to indicate the regions of matching observed peptides to those in the cDNA sequence.
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Figure 4.2 Sequence coverage was represented by yellow region in apo B-100 sequence (P04114). Amino acid 1 through 4563 was shown in the above figure. “A”
represents sample without H2O2 treatment (Blank). This sample was run twice and the sequence coverage data for both run was furnished. “B” represents low peroxide
concentration exposure to LDL (9 µM) (duplicate experiment). “C” represents intermediate peroxide concentration (90 µM) (duplicate experiments). “D” represents
exposure to high peroxide concentration (900 µM) (duplicate experiments). Sequence coverage decreases with increase in peroxide concentration.
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4.4.3. Oxidation of amino acid residues
As mentioned above, tryptic peptides were analyzed by LC-MS/MS. The peptides were
first eluted according to their hydrophobicity immediately followed by introduction to the mass
spectrometer. Individual ions were then selected for collision induced dissociation (CID).
Resulting fragment ions (b and y ions) were used to determine the peptide sequence and possible
modifications to the original peptide sequence♠. Amino acids with aromatic side chains such as
Phe, Trp, and Tyr were previously observed to follow +16 Da mass changes.15, 52 All amino acid
modifications observed in this study are listed in Table 4.3 from duplicate analyses. Oxidations
that were observed in both unoxidized controls and in oxidized samples were omitted from the
table, so all entries in this table indicated peptides that were oxidized by the hydroxyl radical
treatment. In the exposure with the lowest peroxide concentration (9 µM), six different
phenylalanine residues (Figure 4.3) were oxidized by addition of one oxygen atom. Under these
conditions, eight Tyr residues also underwent O addition (Table 4.3 and Figure 4.4).
Direct oxidation of Trp yields kynurenine and N-formylkynurenine. 3898Trp was found
to be oxidized to N-formylkynurenine (+32 Da) (Table 4.3). Trp+16 oxidation product was not
observed. Also, three directly oxidized His residues were observed (Table 4.3 and Figure 4.6).
Under direct hydroxyl radical attack, arginine and proline both take similar pathways and form a
characteristic product, glutamic semialdehyde (Figure 4.7). It should be noted that widely
reported formation of 5-hydroxy-2-aminovaleric acid from arginine and proline was previously
observed in other studies only if a strong reducing agent (NaBH4) was present in the reaction

♠

All positively matched peptides were listed in Appendix A from Table A-1 through Table A-5. Corresponding
Xcorr value and ∆Cn values were also listed.
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medium.53 In our studies, ten oxidized Pro, and no Arg residues were observed in the low
peroxide experiments.
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Figure 4.3 MS/MS spectra of tryptic peptide 3996-4021 from low peroxide concentration depicting modification of 4019Phe (Phe+16 Da).
Corresponding B- and Y- ions are shown. Unmodified peptide was not observed.
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Figure 4.4 MS/MS spectra of tryptic peptide 1001-24 from low peroxide concentration depicting modification of 1020Tyr (Tyr+16 Da). Corresponding
B- and Y- ions are shown. Unmodified peptide was observed and compared with.
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Figure 4.5 MS/MS spectra of tryptic peptide 577-590 from low peroxide concentration depicting modification of 583Trp (Trp+32 Da). Corresponding
B- and Y- ions are shown. Unmodified peptide was observed and compared with.
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Figure 4.6 MS/MS spectra of tryptic peptide 4520–40 from low peroxide concentration depicting modification of 4529His (His+16 Da). Corresponding
B- and Y- ions are shown. Unmodified peptide was not observed.

116

b3 b4 b5 b6 b7 b8

b11b12 b13 b14

y9+1

IEGNLIFDPNNYLPK

1123.37

b11+2
622.29

Direct
modification
of
proline
to
glutamic
semialdehyde [Pro+16]

y3

770.34

y10+1

y7+1
861.35 y +1
8
976.37

1236.36

b13+1
1519.44

y11+1
1349.42

[b14 –H2O]+1

y11y10 y9 y8

[b7 – NH3]+1

y13

Relative Abundance

100

1598.45
0
400

600

800

1000
m/z

1200

1400

1600

Figure 4.7 MS/MS spectra of tryptic peptide 655-69 from low peroxide concentration depicting modification of 663Pro (Pro+16 Da). Corresponding Band Y- ions are shown. Unmodified peptide was observed, compared and accepted as partial modification.
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Figure 4.8 presents a map of all 4563 amino acids for apo B-100. The distribution of
oxidized amino acids is depicted. The figure represents the presence of directly oxidized amino
acids (upward line) and amino acids oxidized indirectly via a lipid radical pathway (downward
line). In addition different colors indicate oxidations observed at low (red), intermediate (blue),
and high (green) peroxide concentrations, respectively. Other colors (black, turquoise and
yellow) represent amino acids that were oxidized in two or more different concentrations (for
example black represents low and high, turquoise represents intermediate and high and yellow
represents the amino acid was oxidized with low, intermediate and high peroxide
concentrations). The red, upward lines indicate amino acids that are most likely solvent
accessible in the intact LDL particle. Because additional oxidations only occurred at higher
concentrations of peroxide, at which there was evidence for loss of protein structural integrity, it
is unclear whether the blue and green lines represent solvent accessible amino acid residues.
These amino acid residues could be solvent accessible but resistant to oxidation (e.g. nearby
residues or lipids might scavenge radicals), or they could be isolated from the aqueous
environment in the protein’s native state, which may have been disrupted by excessive protein
damage.
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Figure 4.8 Plot of observed apo B-100 oxidized amino acids by sequence number [P04114]. Lines indicate
locations of amino acid modification by direct oxidation (upward line) and indirect oxidation/lipid mediated
oxidation (downward line). Red, blue and green lines indicate observed oxidations at low, moderate and high
peroxide concentrations, respectively. Black lines indicate oxidations observed at (low + high), turquoise
represents (intermediate + high) and yellow represents (low + intermediate + high) hydrogen peroxide
concentration. Numbers indicate amino acid residue in the apo B-100 sequence.

119

At the intermediate peroxide concentration (90 µM), only two Phe, no His and one Tyr
residue were found to be oxidized by addition of an O atom (Table 4.3). The number of
observed oxidized amino acid residues was smaller at intermediate and high peroxide
concentrations compared to the low peroxide concentration. At intermediate or high
concentrations of hydroxyl radical, amino acid modification pathways become more complicated
and result in unknown structural changes. Due to the complexity of protein damage, the method
suffers from a decreased ability to identify apo B-100 peptide fragments by LC-MS/MS.
At high peroxide concentrations (900 µM), oxidations were observed at seven Phe
residues, two Tyr residues, and no Trp residue (Table 4.3). Interestingly, a double modification
of 2307Phe (dihydroxyphenylalanine) (Figure 4.9) was observed. Three Pro modifications and
no Arg modification were observed at high peroxide concentration.
Oxidized residues were found to be widely distributed in the protein sequence as
represented in Figure 4.8. In the LDL receptor domains (3130-60 and 3259-67),17 3262Pro
oxidation (Figure 4.7) was observed at low peroxide exposure. This oxidation may lead to
alteration of LDL uptake by LDL receptors in the cell. The wide distributions of oxidation sites
indicate that solvent accessible amino acid residues are spread throughout the protein.
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Figure 4.9 MS/MS spectra of tryptic peptide 2296-2309 from high peroxide concentration depicting modification of 2307Phe (Phe+32 Da).
Corresponding B- and Y- ions are shown. Unmodified peptide was observed and compared.
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4.4.4. Amino acid residues undergoing oxidation via lipid oxidation route
Oxidation of lipids produces stable α,β-unsaturated aldehydes (acrolein or 4hydroxynonenal). These products are hydrophilic in nature and therefore increase the polarity of
some parts of the apo B-100 protein. HNE is prone to react with histidine residues to produce a
mass increase of 156 Da. We did not observe this characteristic mass increase in the oxidized
LDL. However, HNE also attacks the ε-NH2 group of lysine to yield a Schiff base adduct (+138
Da) followed by a water loss and 2-pentylpyrrole adduct formation (+120 Da).27 At low and
intermediate concentrations of peroxide, no HNE-Lys adduct was observed, while at high
concentrations of peroxide, 2195Lys and 2208Lys formed HNE-Lys (Figure 4.10). Previous
attempts were made to identify HNE-Lys adducts in apomyoglobin and apo B-100 by tryptic
digestion method without success.22, 27, 54
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Figure 4.10 MS/MS spectra of tryptic peptide 2195-2210 from high peroxide concentration depicting modification of 2195Lys (K+138 Da) and 2208Lys
(K+120 Da). Corresponding B- and Y- ions are shown. Unmodified peptide was not observed.
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4.4.5. Analysis of natural variants
Seven modified apo B-100 amino acid sequences were constructed to include fifty-one
natural variants and compiled in a small amino acid sequence database (Table 4.2) along with the
apo B-100 sequence (P04114) obtained from the human IPI database. Using tryptic digestion
followed by LC-MS/MS, unique peptides representing a total of four natural variants38-43, 46, 55
were observed in this study (Table 4.4). Mass spectral evidence for the presence of the natural
variant with 2092Leu instead of Val is depicted in Figure 4.11. These natural variants were
confirmed by manual verification of the high quality tandem mass spectra that matched the
variant containing sequences. So far, different studies reported the presence of the natural
variants of LDL based on nucleotide sequence. However, no previous research has directly
identified the presence of these variant amino acid residues in LDL samples via mass
spectrometric data analysis.
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Table 4.2 Reported natural variants were compiled in seven small subsequence databases modified from published sequence (P04114)
[http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?-e+[UNIPROT:APOB_HUMAN]+-newId]. In order to efficiently identify the reported natural variants by
MS/MS, these databases were constructed by incorporating a small group (3-10) of amino acid variants into the P04114 sequence. The sequence
modification table given below demonstrates the subsequences [Seq mod 1, seq mod 2, and so on] created for database search. The natural variants
observed by MS/MS in our LDL experiments are indicated by an asterisk (*).

Seq mod 1

Seq mod 2

Seq mod 3

Seq mod 4

Seq mod 5

Seq mod 6

Seq mod 7
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Tyr>His

741

Thr>Asn

618

Ala>Val

273

Asn>Lys

145

Pro>Ser

733

Val>Ile

98

Thr>Ile

490

Arg>Trp

3527

Arg>Gln

1128 Arg>His

730

Val>Ile

554

Pro>Leu

3182

His>Asn

408

Ile->Thr

1086
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2299 Asp>His

1218

Glu>Gln

1113

Asp>His

3558

Arg>Cys

877

Pro>Leu

1437

Phe>Leu

2739 Pro>Leu

2092*

Val>Leu

1914

Asn>Ser

3964*

Phe>Tyr

1388 Arg>His

1923

His>Arg

3427 Lys>Thr

2680*

Gln>Leu

2365

Thr>Ala

2566 Glu>Lys

2456

Ala>Asp

3949 Leu>Phe

3294

Ser>Pro

2785

Asn>His

3319 His>Asp

3121

Ala>Thr

4481 Ala>Thr

3732*

Thr>Ile

3279

Ser>Gly
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3432
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3945

Thr>Ala

3638

Arg>Gln
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3801
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Thr>Met
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Figure 4.11 MS/MS spectra of tryptic peptide 2086–97 from untreated sample depicting presence of 2092Leu as a natural variant. Corresponding Band Y- ions are shown. Ammonia loss from b5, b6, b7, b8, b9 was observed in the MS/MS spectra.
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4.5. Discussion
4.5.1. Methionine modification
Methionine can be easily oxidized to methionine sulfoxide even by simple exposure to
ambient oxygen (Scheme 3.15). We frequently observed methionine modifications.

These

oxidations were not reported because they were prevalent in control experiments which made it
difficult to verify that the oxidation was the result of treatment with hydroxyl radical.
Some observed oxidized peptides contained both methionine and another oxidizable
residue (e.g. phenylalanine, tryptophan and tyrosine). In these cases, the mass spectral data was
manually checked to determine which of these residues was actually oxidized. These peptides
are identified in Table 4.3 with an asterisk. None of these peptides showed methionine oxidation
in control experiments (no peroxide added), suggesting that these methionine residues were
resistant to oxidation. Methionine modification is characterized by a loss of CH3SOH (-64 Da)
from the precursor ion.56 In Fe2+/peroxide treated LDL, no major peaks in product ion spectra
confirmed this loss. Hence there is no convincing evidence that treated apo B-100 had
methionine oxidations. The presence of inaccessible methionine residues indicates that some
parts of the protein retained their structure during hydroxyl radical exposure. Also, in peptide
2523-34 (observed in high peroxide dose and blank), 2526Met was oxidized and 2523Met
remained intact. Hence it was perceived that some methionines such as 2523Met were in the
hydrophobic pockets of the proteins which are inaccessible to both ambient oxygen and hydroxyl
radical.
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4.5.2. LDL oxidation
It is well recognized that ox-LDL is one of the major factors in promoting atherogenesis.

In vivo formation of ox-LDL and atheroma was extensively demonstrated by several different
studies.4, 5, 7, 8, 57 Our focus was to study apo B-100 oxidation in LDL in the presence of hydroxyl
radical in order to identify the positions of amino acid residues that undergo oxidations under
these conditions. Upon exposure to hydroxyl radical, the most commonly observed modification
was addition of an oxygen atom (e.g. hydroxylation), which resulted in a mass change of +16 Da.
It is expected that the location of these oxidation sites reveals solvent accessible portions of apo
B-100 in LDL. Sharp et al. and other researchers30,

31, 58, 59

demonstrated the usefulness of

hydroxyl radical mapping techniques in model proteins such as lysozyme and β-lactoglobulin A.
In short, the solvent accessible amino acid residues of the protein, particularly those containing
aromatic side chains, react readily with the hydroxyl radical and form an aromatic alcohol. These
are stable markers that can be determined by mass spectrometric studies.
Addition of two oxygens to 2307Phe from low peroxide dose and addition of two
oxygens to 3923Phe from high peroxide dose (Figure 4.9) depicts extensive reactions in some
protein regions. Most observed oxidations were the result of direct hydroxyl radical attack on the
amino acid residues, and only a small portion of the observed oxidations were representative of
lipid mediated oxidation (i.e. involving a lipid radical). The overwhelming majority of direct
oxidation products suggests that at the lowest radical concentration used in this study, little
indirect oxidation occurred in the time frame of these experiments, which was likely too short to
exceed the lag period.60,

61

Furthermore, peptide sequence coverage by LC-MS/MS was

unchanged between LDL not exposed to oxidants and LDL exposed to low concentrations of
hydroxyl radical. This result indicates that low concentrations did not cause enough structural
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damage to interfere with the analysis. However, for higher radical concentrations, dramatic
decreases in sequence coverage were observed indicating that the higher radical concentrations
resulted in extensive protein damage.
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Table 4.3 Modifications of amino acids observed in LDL exposed to three different hydroxyl radical concentrations. Numbers represent the position of
the amino acid in the apoB sequence (P04114). All experiments were done in duplicate. The positions of the oxidized amino acids were compared with
the control. The table includes only oxidations not also appearing in control experiments (no peroxide added). All modifications from each replicate
were listed.

Modifications

Low Peroxide concentration

Intermediate peroxide

Observed
F+16

High Peroxide concentration

concentration
680*, 883*, 2665*, 2845*, 4019*,

1193*, 2419*

680*, 883*, 1193*, 2307, 2419*,
2665*

4531
F+32

3923

N.D.

2307

Y+16

56, 144, 276*, 1020, 3295 3926,

4510

2568, 4380*

4380*, 4451
W+32

583

N.D.

N.D.

H+16

596, 2507*, 4529

N.D

N.D.

P+16

65, 145, 663, 1007, 2620, 2659*,

4004*

663, 3281, 4004*

3262*, 3293, 3310, 3593
K+120

N.D.

N.D.

2208

K+138

N.D.

N.D.

2195

*These peptides contained a methionine residue. Differentiation between methionine oxidation and oxidation of another amino acid in
the same peptide is difficult. However, characteristic loss of 64 Dalton from oxidized methionine was not observed, so methionine
oxidation was ruled out.
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Previously, FDP-Lys (Lys+94)62 and MP-Lys (Lys + 96)63 oxidation products were
observed in samples exposed to hydroxyl radical. Also acrolein forms as a lipid oxidation
product from hydroxyl radical mediated oxidation that can react with amino acid residues such as
Lys and His. FDP-Lys is the result of these oxidations.22, 26 Uchida’s pioneering work in this area
already revealed that by MS/MS methods, these products were extremely difficult to identify due
to extensive cross-linking. In previous work, only 4 molecules of FDP-Lys/molecule of apo B100 were formed during hydroxyl radical mediated oxidations.25, 26 FDP-Lys was not observed in
our studies. It is apparent that in our experiments, the lipid mediated pathway is not predominant.
In previous researches the abundance of MP-Lys, FDP-Lys and HNE-His formation from Cu (II)
mediated oxidations were substantial,22 indicating that Cu (II) mediated pathways oxidize the
protein in a substantially different way compared to direct hydroxyl radical attack.
Exposing LDL to three different hydroxyl radical concentrations showed concentrationdependent oxidation. At low hydroxyl radical concentrations (low peroxide doses), amino acid
oxidations were observed, but no extensive protein structural damage was observed. At higher
hydroxyl radical concentrations, apo B-100 was modified extensively and loss of its native
structure was observed. During in vivo oxidative stress, a lag phase is generally observed in
which the cell or the tissue can recover from the damage by means of its defense mechanisms60,
61

such as antioxidants and repair processes. Nevertheless, oxidative stress in the lag phase can

still induce some damage to apo B-100. In our low hydroxyl radical concentration experiments,
apo B-100 was partially oxidized, but based on the fact that sequence coverage remained high, it
is not likely that extensive structural damage occurred. The low hydroxyl radical dose in this
study is likely representative of the lag phase, and is therefore more relevant to in vivo systems.
The in vitro studies reported here with different peroxide concentrations are significant since
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physiological concentrations of hydroxyl radical are low, but during oxidative burst, neutrophils
generate micromolar amounts of peroxide64 in the cells. The choice of low, intermediate and high
concentrations of hydrogen peroxide elucidated varying degrees of protein damage as a function
of hydroxyl radical concentration.
Ox-LDL uptake by CD-36 into macrophages is a complicated process and not yet
completely understood65. Recent research has correlated the uptake of oxidized phosphatidyl
choline by the scavenger receptor CD-3666. However, dose dependent formation of oxidized
epitopes in apo B-100 can play a crucial role in macrophage uptake and thereby pathogenesis of
atherosclerosis.
Natural variants were previously reported for hemoglobin with the help of mass
spectrometric data.67,

68

Natural variants in apo B-100 were previously observed by other

researchers based on cDNA and expressed sequence tag data. The peptide sequence for apo B100 is extremely complex bearing two alleles in the gene, both of which can be expressed. Gene
expression from two alleles can lead to more than one form of protein or even a mixture of
proteins. The presence of a large number of natural variants could be a result of this complex
gene expression. For our work, all previously reported natural variants were incorporated in
seven small sequences and added to the main database for apo B-100 for peptide searching in
mass spectral data. The search results against the small databases revealed unique peptides
depicting the presence of natural variants in the protein itself. A total of four different amino
acids were found to be present as natural variants in the LDL sample used in this study. These
natural variants can possibly be attributed to polymorphism, mutations or disease state of apo B100 genes.
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Table 4.4 List of natural variants observed in native and ox-LDL from LC-MS/MS experiments, for native
LDL a total of two samples was analyzed. For ox-LDL six samples were analyzed and tabulated.

Natural variants
observed native LDL

Natural variants
observed in ox-LDL

2092Leu
2680Leu
3964Tyr

2092Leu
2680Leu
3732Ile
3964Tyr

4.6. Conclusions
In LDL protein several amino acid residues were found to be oxidized directly or
indirectly by hydroxyl radical. The mass changes due to the oxidation of amino acid residues
such as phenylalanine and tyrosine were analyzed by LC-MS/MS. Oxidized amino acid residues
were distributed widely throughout the apo B-100 sequence. At the lowest radical concentration
used in this study, protein modifications were minor enough to allow successful MS/MS
mapping, and the results suggest that this concentration is effective for mapping solvent
accessible amino acid residues.

Higher radical concentrations, however, resulted in lower

recovery of recognizable peptides, indicating substantial structural damage may have occurred to
the protein. Consequently, these higher concentrations are not as reliable for mapping solvent
accessibility. The vast majority of peptide modifications observed in this study were from direct
hydroxyl radical attack, indicating that our methods represent probing of protein damage in the
lag phase before substantial concentrations of secondary radicals can be formed. Because natural
defenses against free radicals are present in vivo, the lag phase is most likely representative of in

vivo conditions. Consequently, the method reported here avoids complications arising from
oxidation under conditions that are too aggressive (e.g. Cu2+ mediated oxidation). Modification
of 3262Pro was observed in the receptor binding regions17, 69 of apo B-100 (3130-60 and 3259-
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67), indicating that hydroxyl radical can cause direct oxidation in this important region. The
identity and location of the solvent accessible peptides, as well as their oxidation products, will
be helpful in understanding the mechanisms of in vivo LDL oxidation. Furthermore, the protein
modifications identified here may allow studies that elucidate the impact of these modifications
in model systems.
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Chapter 5.
Hypochlorous acid and peroxynitrite treated apo B-100 in LDL: A
study of the oxidized regions of LDL protein
5.1. Abstract
Low density lipoproteins (LDL) act as a major cholesterol carrier in the human
physiological system. Oxidized LDL (ox-LDL) has been found to be pro-atherogenic by several
previous studies. Free radical mediated oxidations of apo B-100 (LDL protein) plays a critical
role in early stages of plaque formation in the arterial wall. The structure of apo B-100 is still
poorly understood, although this structure may be crucial in identifying the role of the protein in
atheroma formation. In this study we mapped the oxidized regions of apo B-100 in human LDL
using peroxynitrite and hypochlorous acid as probes. In a separate experiment, tyrosine was
exposed to peroxynitrite in PBS buffer spiked with bicarbonate. The resultant reaction mixture
was analyzed by reversed phase HPLC and the concentration of 3-nitrotyrosine was calculated.
This result was correlated with the effective concentration of peroxynitrite for protein damage.
LDL was incubated with various concentrations of sodium hypochlorite in bicarbonate buffer.
Previously, we treated LDL with hydroxyl radical and identified oxidized amino acids of apo B100. We employed the same method to identify positions at which peroxynitrite and
hypochlorous acid oxidizes apo B-100. After exposure to peroxynitrite and hypochlorous acid,
LDL was delipidated and dialyzed against methanol:water followed by a treatment with DTT
and iodoacetamide to break disulfide linkages. The resulting solution from peroxynitrtie was
digested with trypsin to yield peptides. Trypsin and pronase both enzymes were used separately
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in hypochlorite treated samples. The peptides are then analyzed by LC-MS-MS to identify
modifications in the protein. Nitrotyrosine and nitrotryptophan, along with hydroxylated amino
acids, are specific markers for peroxynitrite mediated oxidations in proteins. Chlorotyrosines
were specific markers for hypochlorous acid mediated damage in proteins. By employing dose
dependent oxidations of peroxynitrite and hypochlorous acid we have identified site specific
oxidations caused by the oxidants in apo B-100 associated with intact LDL particle. Oxidative
mapping of apo B-100 will reveal solvent accessible regions of apo B-100 and provide valuable
protein structural information related to oxidative protein damage.

Keywords: LDL, ox-LDL, apo B-100, peroxynitrite, hypochlorous acid, oxidative
mapping, LC-MS/MS, trypsin, pronase.
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5.2. Introduction
Low density lipoproteins (LDL) are cholesterol transporters in physiological systems.
LDL particles are comprised of three components: the LDL core has cholesteryl esters and
triacylglycerol, the outermost layer contains phospholipids and free cholesterol, and a single
monomeric protein apo B-100 (4563 amino acids) encircles the lipid assembly (Figure 3.3) and
is partially exposed at the surface of LDL.1, 2 A variety of strong oxidants can damage LDL and
induce formation of oxidized LDL (ox-LDL). Pathological implication of ox-LDL in body is
severe and could be attributed to atherosclerosis.3-8 Atherosclerosis is a complex disease
involving plaque formation in arterial intima. Plaque renders inelasticity in arteries and causes
complicated symptoms in cardiovascular diseases.
Oxidants can damage LDL in a bidirectional fashion. Oxidative stress renders formation
of lipid peroxides and highly reactive aldehydes which are known to disrupt the protein
structure.9-11 Oxidized apo B-100 could also be a key factor in plaque formation. This hypothesis
was supported by the observation that elevated concentrations of the oxidized protein were
accumulated in the atherosclerotic lesions.4, 12, 13 Post translational modification of this protein by
free radical or enzymatic processes may be a key parameter in initiating plaque formation.
Current methodologies are inadequate to completely understand the tertiary structure of this
protein. Molecular modeling, although very useful in some cases, becomes speculative for this
protein14-16 and requires additional information to predict the structure (4563 amino acids and
550 KDa). Due to lipid association, it would be even harder to crystallize this protein. Previously
we observed that liquid chromatography coupled with mass spectrometry (LC-MS/MS) could be
a useful approach in understanding the structure of LDL protein.17 Oxidatively and/or
enzymatically modified LDL particles are inflammatory and activate cytokines and monocyte
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adhesion molecules.18-20 Generally, LDL particles are internalized by LDL receptors which are
expressed ubiquitously in cells. However, oxidative modification in apo B-100 in endothelial
cells promotes binding and uptake of ox-LDL by scavenger receptor CD-3621-26 in macrophages.
This phenomenon becomes more relevant in endothelial dysfunction and initiation of
atherosclerotic plaques.
Due to the enzymatic activity of endothelial nitric oxide synthase (eNOS), L-arginine is
converted to citrulline, releasing nitric oxide in the process.27, 28 Nitric oxide works as a signaling
molecule and helps in vasodilation.27, 28 In vascular endothelial cells, peroxynitrite (ONOO¯ ) is
formed (Scheme 3.3) due to the reaction of nitric oxide and superoxide.29-32 Peroxynitrite is a
very strong oxidant and cause nitration in LDL.18, 33, 34 Indeed peroxynitrite can adapt multiple
pathways (Scheme 3.4) to damage the proteins.35 One of the key reactions of peroxynitrite is
nitration of tyrosine residues to form 3-nitrotyrosine (3-NT)36 (Table 5.1) in LDL protein.37
Myeloperoxidase (MPO) can catalyze this reaction by forming intermediate complexes.
Bicarbonate or dissolved carbon dioxide play an important role in forming tyrosyl radical and
enhance reaction between tyrosyl radical and nitrite radical to form 3-NT.38 Tryptophan
oxidation products were also reported in proteins including changes in the phenyl ring and
nitration in the phenyl ring (Table 5.1). Other amino acids can undergo hydroxylation reaction by
this pathway since hydroxyl radical is also involved as a dissociation product of peroxynitrite.39
During respiratory burst, phagocytes release superoxide and hydrogen peroxide. In the
presence of the heme enzyme myeloperoxidase, hydrogen peroxide reacts with physiological
concentrations of chloride to form reactive hypochlorous acid (HOCl).40 Also, HOCl can be
generated in an extracellular matrix which can cause damage to circulatory LDL in blood
plasma. The damage arising out of hypochlorous acid could be substantially diverse.41, 42 It can

144

cause side chain oxidation, peptide bond fragmentation and aggregation of proteins.42, 43 A range
of amino acid oxidation products were previously published in literature and some of them are
listed in Table 5.2. Controversial results existed on the more susceptible oxidizable regions of
LDL; however, Hazell and co-workers proved that amino acids in apo B-100 are more
oxidizable44, 45 by HOCl compare to its lipid counterpart. It was shown that initial oxidation in
protein apo B-100 can oxidize the lipids and lead to the formation of cholesteryl ester
hydroperoxide. Hazen et. al. depicted tyrosine chlorination in LDL to form chlorotyrosine in
atherosclerotic lesions.46 An increase in oxidation of LDL particles increased the uptake of oxLDL by scavenger receptor CD36, which in turn induced foam cell formation.21, 22 These steps
are considered to be major early events in plaque formation in the arterial wall.
Bergt et. al. presented valuable information on chloramine transfer reactions between
HOCl in apo A-I and high density lipoprotein (HDL).47 This reaction was coined as one of the
key reactions in hypochlorite mediated damage to proteins. Interestingly, Bergt’s quantitative
work showed that the MPO/H2O2/Cl¯ system chlorinated Tyr192 to a greater extent than that
observed for the other six Tyr residues in the protein. These results indicate that the protein
structure influences the chlorination reactions.47 Cystein, methionine and lysine react directly to
hypochlorous acid. Cys yields corresponding sulfonic acid (Cysteic acid, +48 Da) while
methionine forms methionine sulfoxide (+16 Da).48 Chloramine transfer reactions at the ε-NH2
group of Lys was important since this chloramine can transfer chloride to a nearby Tyr residue
(+34 Da) and go back to its native state.49 Also, aromatic amino acid such as histidine can
participate in transferring the chloramine by initial side chain oxidation. Tryptophan can give
oxidation products of the indole residue (+16 Da).42 The extent of chlorination with
MPO/H2O2/Cl¯ and reagent hypochlorous acid sometimes appeared to be controversial.
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Although it was proposed that under physiological conditions MPO binds directly to the amino
acids in the proteins and induces reactions, reagent hypochlorous acid had produced similar
extent of chlorination in Tyr residues.47, 50
Yang et. al. presented pioneering work by modifying apo B-100 in LDL with HOCl. His
methodology was tedious but nonetheless effective.50 His methods involved purification and
isolation of tryptic peptides from apo B-100 by liquid chromatography after HOCl or MPO
treatment followed by analysis with mass spectrometric method (ESI-MS).50 Recent
developments in LC-MS/MS based methodologies are of paramount importance since it
attenuated analysis time and prodigious sample handling skills.51, 52
Free radical53-56 and non-free radical36, 46 mediated oxidations leave permanent footprints
in the side chains of amino acids of proteins (Table 5.1 and Table 5.2). By identifying these
footprints, the solvent accessible parts57-59 (rather aqueous accessible regions) could be
identified. Previously we have shown usefulness of LC-MS/MS based methodologies in
determining oxidative post translational modifications (with hydroxyl radical) in apo B-100.17 In
this article we have assessed the site specific oxidations of apo B-100 in LDL with oxidant
peroxynitrite and hypochlorous acid. We hope this result will help us to understand the solvent
accessible residues in apo B-100, the structure of the protein in LDL and important oxidation
products.
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Table 5.1 Reported amino acid oxidations from literature and associated structural changes after oxidation by peroxynitrite.33, 35, 60-62

Amino acid

Modified amino acid

Associated mass
change

Tyrosine

NO2

3-Nitrotyrosine
C
H2

OH

NO2

Nitro-tryptophan

Tryptophan

C
H2

NH

Tryptophan

+45 Da

C
H2

+45 Da

NH
OH

Hydroxylated

+16 Da

tryptophan
C
H2

Cystein

NH

C
H2

SH

C
H2

NH

O

Cysteic acid
C
H2

S
O
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+48 Da
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Table 5.2 List of amino acid oxidations by hypochlorous acid. 36, 46, 48, 50, 63-66

Amino acid

Modified amino acid

Associated mass
change
Cl

3-Chlorotyrosine

Tyrosine

C
H2

OH

Cl

3,5-Dichlorotyrosine

Tyrosine

C
H2

+34 Da

C
H2

OH

+68 Da
OH

Cl

Tryptophan

2-oxindole

CH2
OH

Cystein

O

N
H

C
H2

+16 Da

H2 C
N
H

NH

C
H2

SH

O

Cysteic acid
C
H2

S
O
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+48 Da
OH

5.3. Materials and methods
Human low density lipoprotein (LDL) was purchased from VWR chemicals. Each batch
of LDL was acquired from a single, healthy human subject. LDL was stored with 150 mM
ethylenediaminetetraacetic acid (EDTA) (pH 7.4) and was kept refrigerated (4 °C). Pronase was
purchased from VWR chemicals. Micro-dialysis tubes and floats were also purchased from
VWR. Sodium nitrite (NaNO2), hydrogen peroxide (30%) and all solvents were purchased from
Sigma-Aldrich (St. Louis, MO). High purity (98%) DL-tyrosine, sodium hypochlorite (NaOCl)
(15% chlorine content), ammonium bicarbonate (ABC), formic acid, dithiothritol (DTT) and
iodoacetamide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Trypsin was
purchased from Promega (Madison, WI, USA). In all experiments, purified water was obtained
by distillation, deionization, carbon filtration and UV irradiation.

5.3.1. Synthesis of peroxynitrite
Peroxynitrite was synthesized by using two peristaltic pumps. This is a slight
improvement to the conventional method.67, 68 In short 0.60 (M) NaNO2 solution was mixed with
0.65 (M) H2O2 (in HCl) at 29ml/min. This mixture was added drop wise to a constantly stirred 3
(M) NaOH solution for quenching. Since, peroxynitrite is extremely unstable in acidic medium
(half life <1 ms) it is necessary to quench the reaction without any delay. The yellow colored
solution indicates the existence of peroxynitrite in solution. This reaction is exothermic in nature
therefore NaOH solution was placed over ice. Excess H2O2 was degraded by transferring the
mixture to a beaker containing MnO2. Bubbles issuing from the solution indicated degradation of
peroxide. Solutions were transferred to 2 mL centrifuge tubes and stored at -80 °C until further
use.
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5.3.2. Characterization of peroxynitrite and quantification of 3-nitrotyrosine
Each day one centrifuge tube of peroxynitrite was taken out from the freezer and thawed
over ice. A pinch of MnO2 was added to ensure residual H2O2 removal from the solution. 25 µl
of this solution was diluted to 3 ml in 0.1 M NaOH and absorbance measurement was taken.
Concentration of the said peroxynitrite solution was calculated from its absorbance at 302 nm (ε
= 1670 M-1 cm-1).69
High performance liquid chromatography (HPLC) was used to measure the amount of 3nitrotyrosine (3-NT) formed after reacting peroxynitrite with DL-tyrosine (0.5 mM) in phosphate
buffer saline (PBS at pH 7.4) and 25 mM ammonium bicarbonate. Initially peroxynitrite
concentration was estimated by previously described absorbance method.69 Three different
peroxynitrite concentrations (10 µM, 100 µM and 1000 µM) (duplicate experiments) were used
for exposure. Reactions were stirred for 30 minutes, acidified and injected into the HPLC to
measure the amount of 3-NT formed. A total of six samples were analyzed.
An Alltech 150 mm C18 (5 µ particle size, I.D. 4.6 mm) column equipped with a 100 µl
loop was used in the HPLC. An isocratic solvent system, 95% water (0.1% Trifluoroacetic acid)
and 5% acetonitrile was used as eluent with a ten minute run time. 3-Nitrotyrosine was injected
as an external standard and a calibration curve was formulated from peak area under HPLC trace
everyday (R2 > 0.99) with three 3-nitrotyrosine standards analyzed in duplicate.

5.3.3. Reagent hypochlorite characterization
Sodium hypochlorite was stored at 4°C until use. Absorbance of NaOCl was measured in
0.01 M NaOH. Concentration was calculated from molar extinction coefficient (ε = 350 M-1 cm-

150

1

) at 292 nm.70 Hypochlorite solution was diluted to desired concentration with 0.01 M NaOH

and stored over ice until addition to LDL.

5.3.4. LDL oxidation
Stock protein concentration was 4.10 mg/mL. For each sample, 12.19 µL LDL was
diluted to 100 µL with ammonium bicarbonate buffer (pH adjusted to 7.4) and placed in micro
centrifuge tubes. A total of eight samples were used in each set of experiments. Each exposure
was carried out in duplicate. Three microliters of peroxynitrite (stock concentration 0.273 mM,
2.733 mM or 27.33 mM) was added to exposed samples maintaining the final concentration of
peroxynitrite in LDL sample as 10 µM, 100 µM and 1000 µM respectively. Three microliters of
0.1 M NaOH was added as blank.
Sodium hypochlorite exposure to LDL was carried out similarly. 12.19 µl NaOCl stock
was diluted to 100 µl by ammonium bicarbonate (pH 7.4). Three microliters of NaOCl
(concentration 0.343 mM, 3.43 mM and 34.3 mM) was added to each LDL sample to start with
the concentration 10 µM, 100 µM and 1000 µM respectively. 3 µl 0.01 M NaOH served as
blank. Again each exposure was carried out in duplicate.
The micro centrifuge tubes are transferred to a temperature controlled shaker (Eppendorf
Thermomixer R). At 37 °C and 900 rpm the reaction was shaken for 10 minutes. An additional 3

µl of peroxynitrite/NaOCl solution was added and shaken for another 10 minutes. Finally, 3 µl of
peroxynitrite/NaOCl was added again and shaken. After 10 minutes these reaction mixtures were
transferred to previously labeled microdialysis tubes.
The samples were then dialyzed against 500 mL methanol:toluene:methylene chloride
(3:1:1) (v/v) for two hours at 4 °C for delipidation. The dialysis float was transferred to another
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500 mL solution containing 300 mL methanol with 200 mL water for another two hours of
dialysis. The cloudy protein solutions were collected and transferred to micro-centrifuge tubes.
BCA assay method was used to estimate the protein concentration at this stage. The protein
solution was boiled in water for 10 minutes to initiate denaturing. Thirty molar excess
dithiothritol was added, and samples were incubated for 30 minutes at 37 °C to cleave the
disulfide linkages. Next, 30 molar excess iodoacetamide was added and let react for 90 minutes
at 37 °C for alkylation of the cysteinyl residues. Tryptic digestion (one blank and three exposed
samples) was carried out overnight following previous methods.17, 71, 72 The tryptic peptides were
quenched with liquid nitrogen, vacuum dried and stored until further use.
Pronase digestion73, 74 was carried out on one batch of NaOCl (exposed to 10 µM, 100

µM and 1000 µM) treated samples. The enzyme was dissolved in water immediately before
addition to protein samples that were exposed to NaOCl (one blank and three exposed samples).
The protein to pronase ratio was calculated by using the enzymatic digestion of bovine serum
albumin (BSA) and optimized as 50:1 (protein:enzyme) (data not shown). Based on the
estimated LDL protein concentration, required pronase was added and samples were incubated at
37 °C for 24 hours. 5 µl formic acid (99%) was added to the samples to quench the reaction
followed by boiling for five minutes. The reaction mixture was then evaporated and dried
peptides were stored at -80 °C. Dried peptides were reconstituted in 5% aqueous formic acid
with 5% acetonitrile for LC-MS/MS analysis. Samples were stored at -20 °C until analysis.

5.3.5. LC-MS/MS of apo B-100 peptides
The peptide mixture obtained from the procedure noted above (maximum amount
equivalent to 3 µg protein) was first loaded onto a reversed-phase trap column, and then washed
with 3% acetonitrile and 0.1% formic acid (aq) to desalt the sample. After the wash/desalt step,
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the trap column was switched into a gradient flow (60 minutes, water with 3% acetonitrile and
0.1% formic acid at the beginning and 65% acetonitrile with 0.1% formic acid at the end) to
elute peptides to a C18 analytical column before introduction into a linear trapping quadrupole
(LTQ) mass spectrometer.

5.3.6. MS setup
Mass spectrometry analyses were performed on an LTQ mass spectrometer (Thermo
Electron, San Jose, CA) equipped with a nano-flow (200-500 nL/min) electrospray source. The
peptides were ionized via electrospray and recorded in a full scan mass spectrum. For each full
MS scan, the top 3 most intense peptide precursor ions were selected and fragmented via
collision induced dissociation (CID). Low pressure helium was employed as damping (for ion
storage and isolation) and collision (fragmentation of activated ions) gas. The instrument was
operated in a highly automated data dependent acquisition mode.

5.3.7. Database search
The database search was performed on an in-house search engine (Bioworks 3.3, Thermo
Electron) using the “SEQUEST” algorithm against human IPI database for apo B-100 (accession
# P04114).75 Peptides with MW of 600-3500 Da were chosen for identification. All
modifications were defined as differential (i.e. the amino acid residue may or may not be
modified) and are listed in Table 5.1. An Xcorr score was generated from the matching of
experimental spectra to the theoretical spectra of apo B-100 peptides. A charge state-Xcorr score
filter was applied to all MS/MS spectra. Singly charged peptides with Xcorr score less than 2,
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doubly charged peptides with Xcorr score less than 2.5, and triply charged peptides with Xcorr
score less than 3.0 were considered as false positives and removed from the final report♣.

5.4. Results and discussion
5.4.1. Quantification of 3-nitrotyrosine with HPLC
In vitro nitration of tyrosine using reagent peroxynitrite followed a complicated
mechanism. In physiological systems, the heme enzyme myeloperoxidase and other artifacts may
facilitate 3-nitrotyrosine formation in proteins. It was important to know the concentration of
peroxynitrite added to the sample. Therefore conventional absorbance method (for peroxynitrite)
and HPLC method (quantitation of 3-NT) were used to verify the consistency between the results
obtained from both of these methods. We have measured amounts of 3-nitrotyrosine (duplicates)
in three different reactions containing three different concentrations of peroxynitrite. For
estimated 10 µM, 50 µM and 100 µM peroxynitrite exposures, we calculated the total amounts
of 3-NT as (1.1 ± 0.1) ×10-10 moles, (5 ± 1) × 10-10 moles and (11 ± 2) ×10-10 moles. This data is
presented in Figure 5.1. 3-NT formation was a measure of nitrite radical formation through
nitrosoperoxycarboxylate pathway after reaction of peroxynitrite and carbon dioxide
(bicarbonate) (detailed discussion in chapter 3). It should be noted that the actual yield of 3-NT
in this reaction is only ∼10% compare to the total peroxynitrite added to the reaction mixture.

♣

All positively matched peptides were listed in Appendix B from Table B-1 through Table B-6. Corresponding
Xcorr and ∆Cnvalues were also included.
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Figure 5.1 3-Nitrotyrosine formation from three different concentrations of peroxynitrite. An increase in 3-NT formation with increasing peroxynitrite
concentration is apparent. Errors are represented as one standard deviation.
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5.4.2. Modification of apo B-100 by peroxynitrite
Identification of the presence of 3-NT in atherosclerotic lesions indicated involvement of
peroxynitrite in the oxidation of proteins.62 Previous research connected nitration of amino acid
residues in LDL to peroxynitrite activity. Eiserich et. al.76 and Kettle et. al.36 suggested
involvement of MPO in protein tyrosine nitration. We however worked in an enzyme free
environment and explored nitration through nitrosoperoxycarboxylate31 pathway. Previously
Alvarez et. al. depicted nitrotryptophan formation by reacting peroxynitrite directly with
tryptophan.61 Yamakura et. al. emphasized on formation of 6-nitrotryptophan formation in Cu,
Zn-superoxide dismutase with peroxynitrite77. From our experiments with reagent peroxynitrite,
we have rarely observed nitration products on Tyr residues. Tryptophan nitration was not
observed at all in the three different peroxynitrite doses.
In low peroxynitrite dose (10 µM), we have observed peptide 1830-52 which represented
both 1840Tyr nitration and 1831Tyr hydroxylation (Figure 5.2) from low peroxynitrite exposure.
Three hydroxylated tryptophans were observed. Oxidation of Cys1505 to cysteic acid (Figure
5.3) was also observed (Table 5.3).
With intermediate peroxynitrite concentration, no nitrotyrosine was observed.
Hydroxylation of the phenyl ring in tryptophan was obviously easier compared to nitration,
although it was mediated through the formation of hydroxyl radical39 by homolytic fission of
peroxynitrite§. It seems plausible that some of the peroxynitrite molecules escape the
nitrosoperoxycarboxylate pathway and simply follow homolytic fission even though the reaction

§

Due to the enormous volume of data tyrosine and phenylalanine hydroxylation was not exclusively considered at
this stage. Hydroxylation of both the amino acids occurs if hydroxyl radical pathway is prevalent. We have mapped
hydroxyl radical mediated oxidations in apo B-100 previously. Due to similar reason this database search was
focused on hydroxylation of the phenyl ring in tryptophan and not on the ring dissociation products kynurenine and
NFK.
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is slower. Trp2248 (Figure 5.4) and Trp3970 oxidation were observed, which is consistent with
the samples treated with the low peroxynitrite dose. Cystein oxidation at intermediate
peroxynitrite concentration revealed interesting events. Hamilton et. al. reported modification of
Cys1112 to its corresponding sulfonic acid by peroxynitrite treatment.37 We have observed
modification of the same amino acid without peroxynitrite treatment. It could be possible that
Cys1112 is highly susceptible to oxidation by ambient oxidants. Three different peptides 110018, 1101-18 and 1001-15 confirmed this modification revealing both +2 and +3 charge state of
the peptides. We have not observed the unmodified peptide in the untreated sample. It will
therefore difficult to be claimed as a modification originating from peroxynitrite in our case.
Due to paucity of the nitrated peptides in our high peroxynitrite experiments, another set
of 1000 µM peroxynitrite exposure experiments were carried out keeping all parameters the
same (Table 5.3). Four tyrosine residues appeared to be nitrated, of which Tyr1602 was not
reported previously. Two products for modification of Tyr2524 were observed. One modified
peptide was nitrated at this position (+45 Da) (Figure 5.5) and the other was hydroxylated (+16
Da) (Figure 5.6). It should be noted here that previous experiments with hydroxyl radical always
showed oxidation of Tyr2524.17
Although Protparameter analysis78 of apo B-100 sequence showed the presence of 151
Tyr residues in the apo B-100, very few of them were nitrated. Hamilton and coworkers37
reported nitration of tyrosine residues in LDL with both reagent peroxynitrite and SIN-1 (nitric
oxide and superoxide donor). Their observations included nitration of 10 Tyr residues in the
presence of 1 mM peroxynitrite. However, it must be noted that physiological peroxynitrite
concentration even in severe conditions could hardly mount to such a high level. Thus our initial
intention was to look at dose dependent nitration of apo B-100 which might reveal important
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aspects of peroxynitrite mediated nitration in LDL. From the results it was apparent that at low
peroxynitrite local concentrations, tyrosine nitrations are not highly favorable. Also peroxynitrite
stays in equilibrium with peroxynitrous acid (ONOOH). If the tyrosine residues are not
completely exposed to the solvent, peroxynitrite/peroxynitrous acid will be unable to access
them.

In

addition,

site

specific

generation

(closer

to

certain

amino

acids)

of

nitrosoperoxycarboxylate could be harder even in in vitro system. If the Tyr residues are close to
lipid associated domains lipid nitrite formation will be facilitated which will minimize the
possibility of formation of 3-NT in LDL.
Furthermore, in all most all of our experiments sequence coverage had decreased
dramatically (data not shown) which could be attributed to severe aggregation and cross-linking
in the protein following peroxynitrite mediated oxidations followed by digestion with trypsin.

5.4.3. Hypochlorous acid mediated oxidations of apo B-100
In vivo flux of hypochlorous acid was attributed to phagocytic activity in and out of the
cells. LDL in circulation can be oxidized79 by HOCl. In vascular endothelial cells, HOCl induces
damages to various reactive amino acid residues by side chain oxidations, fragmentation and
cross-linking.65,

80

The actual species which induces protein damage by hypochlorite are

controversial. The physiologically relevant model system is related to the MPO catalyzed
reaction between peroxide and chloride.36, 66 The amount of hypochlorous acid generation can
vary significantly depending on different artifacts.
In this study we have explored dose dependent site specific oxidation of apo B-100 in
LDL by reagent hypochlorite. Two different enzymes were used to cleave apo B-100 in LDL.
Trypsin digest only reveal ∼50% of the sequence in the peptide matching. Therefore pronase was
used as an alternative proteolytic enzyme. Pronase worked well on bovine serum albumin (data
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not shown). However, it was not substantially effective in the case of apo B-100. Pronase could
cleave the protein into smaller fragments due to non-specificity making it difficult to be detected
by MS/MS methods (Table 5.4).
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Figure 5.2 MS/MS spectra from tryptic peptide 1830-52. Tyr1840 was nitrated while Tyr1831 was hydroxylated.
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Figure 5.3 MS/MS spectra from tryptic peptide 1499-1513 from low peroxynitrite treated samples. The only one cystein oxidation observed in
peroxynitrite treated sample. Cys1505 (+48 Da) was oxidized in this peptide by peroxynitrite.
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Figure 5.4 MS/MS spectra from tryptic peptide 2241-55 from intermediate peroxynitrite exposure. Trp2248 was oxidized to corresponding
hydroxylated tryptophan.
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Figure 5.5 MS/MS spectra from tryptic peptide 2523-34 from high peroxynitrite exposure. Tyr2524 was chlorinated. Met2523 and Met2526 were
oxidized in this peptide.

163

[Precursor-CH3SOH]+2

b4 b5 b6 b7 b8 b9 b10b11

‡
‡
MYQMDIQQELQR
y10

y8 y7y6 y5 y4 y3 y2

776.61

100

Relative Abundance

b2 b3

y5+1
673.23

y4+1
545.23

y3+1
416.18
+1

y2
303.05

Tyr+16 Da

Met+16 Da

y8+1
y7+11029.39
914.35

y9+1
1176.41

b9+1
1199.47
b11+1
1440.31
1576.54

0
500

1000

1500

m/z
Figure 5.6 MS/MS spectra from tryptic peptide 2523-34 from high peroxynitrite exposure (same run as the previous). Tyr2524 was now oxidized (+16
Da). Met2526 were oxidized in the same peptide. Since Met2523 is adjacent it will be difficult to coin the actual oxidation site.
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All observed oxidations in peptides of apo B-100 obtained after pronase digest were
listed in Table 5.4. At low and intermediate hypochlorite concentrations no chlorotyrosines were
observed. At the higher concentration of hypochlorite, Tyr1053 and Tyr1200 (Figure 5.7) were
chlorinated. These chlorinations could be facilitated by chloramine transfers from Lys1251 and
Lys1202 respectively. Interestingly Trp4022 and Trp4396 (Figure 5.8) residues were oxidized to
2-oxindolic form at the intermediate hypochlorite dose. Although these modifications were
observed after digestion with pronase, they were not observed in the tryptic digests. With the
moderate hypochlorite dose, peptides 4010-22 and 4385-98 showed tryptophan hydroxylation.
However, due to batch to batch variability with pronase digestion, these peptides were not
observed in the low or high hypochlorite doses. From pronase digested peptides, cysteic acid
formation could not be confirmed although literature study stated a considerably high rate
constant with hypochlorous acid.65
Pronase is a useful enzyme in protein digestion. However, the non-specific nature of the
enzyme might be detrimental for its usage in digesting large proteins such as apo B-100 which
can be cleaved to very small fragments. Nevertheless, we could be able to identify some of the
regions containing the modified tyrosine and tryptophan residues which did not appear in tryptic
peptides. Particularly indolic ring oxidation products (Figure 5.8 and Table 5.4) were not
identified before in apo B-100 peptides.
Tryptic peptides were compared between treated and untreated samples. Only those
peptides are listed which did not appear in the untreated sample (Table 5.5). In low hypochlorite
exposure (10 µM) Tyr3295 was chlorinated (Table 5.5). At high hypochlorite concentration, this
residue was chlorinated twice, indicating that it is readily susceptible to chlorination in the
presence of hypochlorous acid. However, dichlorination of the tyrosine residues were not
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observed at low hypochlorite concentration. Trp3563 was also observed to yield the
corresponding 2-oxindolic residue in the side chain. No Cys oxidation was observed.
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Figure 5.7 MS/MS spectra from pronase peptide 1193-1202 from high hypochlorite exposure. Tyr1200 was chlorinated was (+34 Da). Notable factor in
this peptide is presence of Lys1202 which can facilitate chloramines transfers.
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Figure 5.8 MS/MS spectra from pronase peptide 4385-98 from high hypochlorite exposure. Trp4396 was oxidized to corresponding 2-oxindole (+16 Da)
derivative by intermediate hypochlorous acid dose.
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Figure 5.9 MS/MS spectra from tryptic peptide 3754-62 from intermediate hypochlorite exposure. Cys3761 was converted to cysteic acid (+48 Da).
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Figure 5.10 MS/MS spectra from tryptic peptide 440-54 depicting chlorination of Tyr443 from high hypochlorite exposure. Tyr452 was not modified
even though His453 and Lys454 in the vicinity.
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Figure 5.11 MS/MS spectra obtained from tryptic peptide 4447-61 depicting dichlorination of Tyr4451. This peptide was observed in high hypochlorite
exposure.
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Figure 5.12 MS/MS spectra of tryptic peptide 3293-3311 indicating monochlorination of Tyr3295 (+34 Da addition).
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Figure 5.13 MS/MS spectra of tryptic peptide 3292-3311 depicting dichlorination of Tyr3295 (+68 Da). This peptide has even better match compare to
the monochlorinated peptide.
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Figure 5.14 MS/MS spectra from tryptic peptide 2535-59 depicting oxidation of Trp2553 and 2554 from high hypochlorite exposure. Corresponding B/Y- ions are observed.
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Table 5.3 Observed amino acid oxidations and associated mass changes from three different peroxynitrite exposures on LDL were tabulated. Trypsin
was used as the proteolytic enzyme. All these modification are unique in nature. Sequence coverage was low in all experiments (data not shown).

Modified amino acids

Low peroxynitrite (10
µM)

Intermediate
peroxynitrite (100 µM)

High peroxynitrite
concentration (1000 µM)

High peroxynitrite
concentration
(1000 µM)

Y+45

1840

−

−

413, 1602, 2524,
3295

W+45

−

−



N.D.

W+16

583, 3970

1461, 2248, 3970

3970

N.D.

C+48

1505

−

−

N.D.

N.D. Not determined. [Data was not searched for W+45, W+16 and C+48].
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Table 5.4 Oxidation of amino acids with three different hypochlorous acid concentrations. Enzymatic digestion of apo B-100 was carried out by
pronase. Results in the treated samples were compared with an untreated sample (blank containing no hypochlorous acid) were listed here.

Modified amino acids

Low hypochlorous acid (10 Intermediate hypochlorous
µM)
acid (100 µM)

High hypochlorous acid
(1000 µM)

Y+34

−

−

1053, 1200

W+16

−

4022, 4396

−

C+48

−

−

−
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Table 5.5 Oxidations of amino acids in presence of three different concentrations of hypochlorous acid. All modifications from duplicate experiments
were included. Trypsin was used as a proteolytic enzyme in these experiments. Amino acids that appeared only in treater sample were listed here
(compared with a blank containing no hypochlorite).

Modified
amino acids

Low hypochlorous acid (10 µM)

Intermediate hypochlorous acid (100 High hypochlorous acid (1000 µM)
µM)

Y+34

3295

−

144, 276, 443, 666, 1200, 1999,
3139, 3295, 3771, 4509/10#, 4534

Y+68

−

−

148, 3295, 4451, 4509/10#

W+16

3563

721, 1461, 2131, 2495, 2553/54,
2686, 3594, 4058

2553†, 2554†,3153, 4058

C+48

−

1112, 3761, 4217

3761

#:

MS/MS is not conclusive enough to pinpoint one single amino acid oxidation in this case. Tyrosine was partially modified to
monochloro and dichlorotyrosine

†:

Two modified tryptophan residues appeared in one single peptide.
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Figure 5.15 Mapping oxidized amino acids of apo B-100 in LDL with peroxynitrite (downward line) and
hypochlorite (upward line). Pink represents oxidation from low peroxynitrite where as yellow and turquoise
represents oxidation from intermediate and high peroxynitrite. Orange represents oxidized amino acids
appearing both in low and intermediate peroxynitrite. Green, blue and red represents oxidized amino acids
from low, intermediate and high hypochlorite exposure. Black represents oxidized amino acids appearing in
both low and high hypochlorite. Plum represents oxidized amino acids appeared both in intermediate and
high hypochlorite exposure. Special characters * represents oxidized amino acids observed both in
hypochlorite and hydroxyl radical mediated oxidations. Special character ^ represents oxidized amino acid
was observed both in peroxynitrite and hydroxyl radical treated samples. Special character † coins oxidized
amino acid appearing in peroxynitrite and hypochlorite treated samples. Special character § coins oxidized
amino acid was observed in all three treatments.
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For experiments at intermediate hypochlorite concentration (100 µM), Tyr-chlorination
was confirmed. Eight tryptophan and three cystein residues were oxidized. No dichlorination
products were observed (Table 5.5).
In high hypochlorite dose experiments, eleven Tyr residues were monochlorinated and
four Tyr residues were dichlorinated. Tyr443 monochlorination was depicted in Figure 5.10.
Tyr4451 dichlorination (mass increase of +68 Da) on the other hand was depicted in Figure 5.11.
Interestingly Tyr3295 appeared in both monochlorinated (Figure 5.12) and dichlorinated (Figure
5.13) form indicating partial modification of the said residues. Cys3761 oxidation was observed
(Figure 5.9) by hypochlorous acid in our samples (Table 5.5).
Positions of the all modified amino acids in apo B-100 was presented in Figure 5.15. The
said figure (Figure 5.15) depicted modification from both peroxynitrite and hypochlorite
including three different oxidant doses. It was evident that the number of chlorination sites
increased with high concentration of hypochlorite. Lys and histidine in the nearby sites can
facilitate the chloramine transfer42 to Tyr residues. For example peptide 3292-3311 has a
histidine residue at 3308. This peptide belongs to the amphipathic β2 strand which has a well
established barrel structure.14 Therefore, His3308 could undergo initial chlorination and take part
in chloramine transfer to chlorinate Tyr3295 (Figure 5.12 and Figure 5.13). Chlorination of
Tyr276 occurred during high hypochlorite exposure. The N-terminal amino acid for this peptide
was 275Lys, which can easily participate in chloramine transfer reactions. Tyr443 (Figure 5.10)
had been one of the most interesting chlorinated tyrosines, which was part of peptide 440-54 and
in close proximity to His447. No evidence was observed in support of 452Tyr chlorination which
was right beside 453His and 454Lys. Probably when hypochlorite was added; it was placed right
beside the His residue which took part in chloramine transfer to Tyr443. Peptide 440-54 belongs
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to βα1 domain of apo B-100, which assumes an intermediate structure between helix and barrel.14
Tyr1999 is in close vicinity of C-term Lys2002 which can help chlorinating the Tyr residue.
4509/10 is an interesting special case where the match is extremely comparable in MS/MS
between the Tyr residues placed side by side. However, drawing exclusive conclusion about
dichlorination of one of Tyr4509 or Tyr4510 residue is difficult just with MS/MS since they are
adjacent to each other. A possibility of monochlorination on both Tyr4509 and Tyr4510 cannot
be overruled. Also model peptidic study involving peptide LQDFSDQLSDYYEK could reveal
mechanistic details about the tyrosine chlorination(s) in the protein.C-term Lys4512 could be
involved in chloramine transfer reactions. One of these residues was also found to be
dichlorinated with a very high score, indicating that chlorination reaction is facile in this region.
Again in peptide140-57 two Tyr144 and Tyr153 (closer to Lys157) were present, although only
Tyr144 was found to be chlorinated. It was apparent that Lys148 is closer to Tyr144 and
facilitating the chloramine transfer reactions with hypochlorite. MS/MS spectra obtained from
peptide 4447-61 contained Tyr4451 which was dichlorinated in the presence of high
hypochlorite concentration. An excellent match in the product ion spectra was observed (Figure
5.11).
Previously, we have identified 5 and 7-hydroxytryptophan residues which were
associated with hydroxyl radical addition to the phenyl ring. However hypochlorite induced
oxidation of tryptophan renders favorable attack on the indole ring to yields a 2-hydroxyindole
residue which stays in its resonance form 2-oxindole.48 Oxidation of tryptophan increased as the
concentration of hypochlorite increased. Also, peptide 2535-59 in intermediate hypochlorite
mediated oxidations have some interesting features. From the MS/MS data it was difficult to
conclude whether Trp2553 or Trp2554 was modified (Figure 5.14). In high hypochlorite
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exposures, we have again observed peptide 2535-59 bearing both Trp2553 and Trp2554
oxidations. Intermediate hypochlorite contained Trp1461 oxidation, which was part of peptide
1451-74. The same peptide contained Met1465. However, CH3SOH loss, which is common for
methionine oxidations, was not observed in the MS/MS spectra. MS/MS matching for
Met1465+16 is comparable to Trp1461+16. Hence methionine modification can not be
completely ruled out in this case.
Cystein oxidation was observed for intermediate and high hypochlorite concentration.
Cys3761 was oxidized to the corresponding sulfonic acid in presence of intermediate and high
concentrations of hypochlorite (Figure 5.9). Observed oxidations at high hypochlorite dose were
lower than that of the intermediate dose, which could be attributed to several reasons including
the lack of accessibility of the same region by trypsin.
It was perceived that high concentration of hypochlorite can bring about various changes
to a protein including peptide bond fragmentation. At this point it would be difficult to
exclusively depict whether apo B-100 is fragmented by hypochlorite. Rigorous data mining are
under current investigation to identify peptides which shows fragmentation by hypochlorous
acid. Conceivably, hypochlorite could induce peptide bond fragmentation in apo B-100. 1-D
SDS-Gel electrophoresis data might be useful, although previous attempts by other researchers
were not quite successful. Several issues were raised indicating difficulties associated with
loading the protein in the gel.79
Hydroxyl radical mediated oxidative mapping and oxidative mapping from peroxynitrite
and hypochlorite showed some similarities (Figure 5.15). Tyr2524, Tyr3295 and Trp583 were
oxidized in hydroxyl radical mediated oxidations as well as peroxynitrite. Where as Tyr144,
Tyr276, Tyr3295, Tyr4451 and Tyr4509/10 were observed both in hypochlorite mediated
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oxidations and hydroxyl radical mediated oxidations. Oxidation of same amino acid residues
using different oxidants emphasizes the fact that this residues are solvent accessible and would
get damaged readily during oxidative stress. Also, some of these amino acids such as Tyr413,
Tyr2524 and Tyr3295 were previously observed to be nitrated with peroxynitrite.37 Dose
dependent oxidations with peroxynitrite and hypochlorous acid to identify the site specific
oxidation emerge as a novel technique which could be useful in identifying the solvent accessible
residues in apo B-100. Although observed oxidations with peroxynitrite were not overwhelming,
we were able to identify Tyr1602 nitration which was not reported before. Yang et. al. produced
interesting work in identifying oxidation sites in apo B-100,81 however, extensive concentration
dependent mapping experiments with hypochlorous acid was not carried out by any research
group.81 It also revealed several different oxidation sites in apo B-100 which was not previously
identified. We hope site specific oxidations data will help us comprehend the structure of the
protein in intact LDL.
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Chapter 6.
Conclusions and future directions
6.1. Accomplishments
Thiourea based fluoride sensing using luminescence methods were investigated in the
initial part of my research. In this context, 1,8-bis(phenylthioureido)naphthalene (compound 1)
was synthesized and characterized (Chapter 2), and its fluoride sensing behavior in acetonitrile
was investigated. This compound was highly selective towards fluoride compared to other
halides, acetate and hydrogen phosphate. A remarkable 40-fold enhancement in fluorescence was
observed in the presence of only five equivalents of tetrabutylammonium fluoride (fluoride
donor). Mechanistic studies indicated strong hydrogen bonding formation between thioureido
protons and the fluoride ion. The compound presented itself as a chromogenic sensor in the same
solvent. Fluoride bound species showed 20 fold higher quantum yield than the unbound species
at the same emission wavelength indicating a superb sensitivity. Theoretical detection limit was
in the range of submicromolar level, which provided low ppm detection of fluoride.
LDL protein oxidations and their implications in atherosclerotic plaque formation is an
important aspect to understand cardiovascular disease risk factors. In this research we have
produced ample data to support the hypothesis that free radical mediated oxidations of apo B-100
in LDL is site specific. Extensive oxidations however might induce irrevocable changes in the
protein. Metal catalyzed oxidations with variable concentrations of hydrogen peroxide revealed
substantial oxidations in the proteins. Several different oxidation sites in apo B-100 were
identified by using LC-MS/MS based methodologies (Chapter 4). These sites were distributed all
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throughout the apo B-100 sequence. We have also identified some reported natural variants by
using a novel database search method (Chapter 4).
Furthermore, we have also used the oxidants peroxynitrite and hypochlorite to identify
oxidation sites in LDL. Different side chain oxidations in amino acid residues were observed
(Chapter 5). It appears that peroxynitrite is very selective in nitrating the amino acids while
hypochlorite could chlorinate several tyrosine residues in apo B-100. The nitration and
chlorination in amino acid residues in LDL induce structural changes in apo B-100 which might
be critical to its function. How these structural changes are directly propagating the plaque to
cause disease advancement are still to be understood.

6.2. Future directions
Over the years fluoride remained as a fascinating ion to the scientists and researchers due
to its critical behavior in health and environmental subjects. Fluorescence enhancement based
fluoride sensing gives better detection than that of fluorescence quenching based fluoride
sensing. Urea and thiourea based naphthalene were depicted as an excellent candidate primarily
due to improve planarity1, 2 after binding to fluoride and also due to lack of relaxation via twisted
conformations3, 4. Our success in detecting micromolar to submicromolar levels of fluoride by
compound 1 revealed several new vistas of research. The proposed research is furnished below:

 Synthesis and characterization of similar thioureido analogues and exploitation of their
binding behavior towards fluoride. Synthesis of these analogues is complex and requires
exploration of improved synthetic routes. Changing the substituents in the phenyl ring as
well as in the naphthalene ring might bring about important changes in the electronic
configuration of the molecule, consequently changing fluoride detection and the binding
properties of the molecules. Previous articles, proposed 1:1 binding between fluoride and
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anthracene thioureido compounds. However, naphthalene thiourea could be a completely
different case. In our studies, we observed evidence for the presence of 1,8-bis(4methoxyphenylthioureido)naphthalene during the reaction of 1,8-diaminonaphthalene
and 4-methoxyphenylisothiocyanate. However, purification did not yield sufficient
quantity of product to carry on with fluoride sensing experiments.

 Immobilization of naphthalene thiourea based analogues to a nanoparticle or a fiber optic
to enable detection of the fluoride in aqueous solutions. This approach could resolve the
water solubility issue of naphthalene thiourea analogues. Kim et. al. were able to
immobilize anthraquinone based receptors to mesoporous silica and silica particles5.
Immobilization of these sensing molecules on solid supports will expand the use of
thiourea based sensing molecules to detect fluoride in aqueous media where interfering
effects could be minimized.
Low density lipoprotein is of major interest to researchers due to its implications in
atherosclerosis. Protein surface mapping is a unique technique for identifying oxidatively
modified surface amino acids in proteins. Identification of these sites reveals important structural
information of the proteins. In our research, several oxidized amino acid residues were identified
in LDL protein resulting from oxidants such as hydroxyl radical, peroxynitrite and hypochlorous
acid. Some of the new and improved approaches are listed below which could allow us to expand
the boundary of the current research. Additionally, the following approaches could also help us
answer critical issues associated with current LDL research and the importance of LDL in
atherosclerosis. The recommendations are:

 The oxidation sites from the in vitro LDL experiments provided us the insight that
hydroxyl radical mediated oxidations occur to those amino acids which are solvent

192

accessible or close to lipid permeable layer. We, therefore, would like to map the surface
of this protein on LDL samples acquired from patients with different levels of
atherosclerosis (assuming that they went through in vivo oxidative stress) and match
those site specific oxidations with our in vitro data. Dr. Jim Oates of MUSC, South
Carolina kindly has consented to provide us LDL samples for this research.

 Oxidation of peroxynitrite was done so far with reagent peroxynitrite. A second nitric
oxide donor 3-morpholinosydnonimine hydrochloride (SIN-1) (releases peroxynitrite in
situ) should be used along with peroxynitrite in a dose dependent fashion to verify the
site specific oxidations of apo B-100. Peroxynitrite is a potent oxidant and can cause
fragmentation of the peptide backbone. SDS gel electrophoresis data will be useful in
identifying these fragments from LDL protein. Also, oxidized LDL samples obtained
from patients could again be very useful in validating the data obtained from in vitro
experiments.

 In vitro hypochlorite addition showed site specific chlorination and other oxidations in
the LDL protein. However, peptide backbone fragmentation was not largely explored in
our current experiments. Hypochlorite being an extremely strong oxidant showed protein
fragmentations in other model systems6,

7

Again SDS gel electrophoresis data should

reveal important aspects of variable hypochlorite mediated oxidation of apo B-100 in
LDL.

 In a related but slightly different subject, myeloperoxidase, hydrogen peroxide and
chloride should be used to initiate more physiologically relevant hypochlorous acid
oxidant system to oxidize LDL. This system will exclusively provide evidence on
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whether there are any differences in site specific oxidations between reagent hypochlorite
and MPO/H2O2/Cl-.8

 All through our LDL work we have perceived the fact that enzymatic digestion is a key
factor in identifying peptides by LC-MS/MS based techniques. Trypsin was an enzyme of
choice owing to its broad applicability and ease of use. However, other enzyme systems
could also be useful. Use of pronase was partially explored in hypochlorite mediated
oxidation of LDL. With slight modifications in the digestion protocol, pronase9, 10 could
be considerably useful in generating substantial amounts of peptides from apo B-100,
particularly due to its non-specific nature. Also chymotrypsin should be explored for the
same reason9. Combination of enzymes might also increase the number of peptides from
apo B-100, which in turn could be useful for matching them with the database.

 To address the problems associated with tryptic digestion and recovery of peptides after
digestion, enzyme immobilization in microfluidic chip11-13 or other devices14-16 could be a
powerful alternative approach. Microfluidics involving in-line digestion coupled with
LC-separation and tandem mass spectrometry will bring about revolutionary changes in
the complete aspect of the proteomics research associated with large proteins such as apo
B-100.

 Natural variant identification by novel database search method could be useful as a rapid
screening method in identifying modifications in proteins. We believe this methodology
will provide significant support in early screening of samples for disease related
mutations in proteins.
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The strong practical impetus for LDL research is associated with human health and our
future research will definitely provide answers to some long standing questions associated with
risk factors in cardiovascular diseases.
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Appendix A
Table A-1 List of peptides depicting various modifications observed in tryptic peptides (unique positive match) ]obtained from apo B-100 after low
peroxide exposure (sample 1).

.
AA
modification

Dta #

Peptide

AA sequence for the peptide

Chg
State

Xc

∆Cn

F+16

1722-28

3996-4021

GISTSAASPAVGTVGM*DMDEDDDF4019SK

+3

4.60

0.24

+2

4.42

0.27

+3

3.48

0.23

+3

3.70

0.27

+3

3.83

0.07

+3

3.54

0.47

+2

5.66

0.78

+3

6.30

0.57

+3

3.25

0.39

+3

3.84

0.26

+2

3.54

0.63

+2

3.48

0.24

+2

3.50

0.34

2354-68
2674
2734-36
3033
F+32
Y+16

H+16

2624

670-95
2645-69
4520-40
3906-35

PSVSVEF VTNMGIIIPDFAR
680

ESMLKTTLTAF GFASADLIEIGLEGK
2665

FSTPEFTILNTFHIPSFTIDF

VEMK

4531

LIDLSIQNYHTF

LIYITELLK
3923

ADYVETVLDSTCSSTVQF

LEY

3926

ELNVLGTHK

54

1750-52

52-71

YTYNY EAESSSGVPGTADSR

2624

3906-35

Same precursor ion as 2624 in F+32

2877-81

4359-85

FNEFIQNELQEASQELQQIHQY4380IMALR

2498-2504
3033

P+16

877-96

883

1678-80
2655
2772-78

591-613
4520-40
52-71
3292-3311
3254-76

596

NFVASH IANILNSEELDIQDLKK
LIDLSIQNYH

4529

TFLIYITELLK
65

YTYNYEAESSSGVP GTADSR
VPSYTLILPSLELP
PVVNVEVSP

3305

VLHVP

3262

3310

R

FTIEMSAFGYVFPK
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Table A-2 List of peptides depicting various modifications observed in tryptic peptides (unique positive match) obtained from apo B-100 after low
peroxide exposure (sample 2).

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

F+16

1885-92

3996-4021

GISTSAASPAVGTVGM*DMDEDDDF4019SK

+2

3.42

0.67

Y+16

883

2403-11

877-96

PSVSVEF VTNMGIIIPDFAR

+2

4.25

0.25

2827-34

2645-69

FSTPEFTILNTFHIPSFTIDF2665VEMK

+3

3.61

0.25

+2

3.09

0.54

+3

5.22

0.03

+3

3.44

0.04

+2

3.57

0.58

+3

6.08

0.50

1940-47

276-87

276

Y GMVAQVTQTLK

2211-16

1001-24

LELELRPTGEIEQYSVSATY

2223

140-57

QVFLY144PEKDEPTYILNIK

1020

ELQR

4451

2392

4447-61

NIQEY

LSILTDPDGK

2623

3292-3311

VPSY3295TLILPSLELPVLHVPR
583

W+32

2159

577-90

IVQILPW EQNEQVK

+2

3.13

0.34

H+16

2889-94

2489-2509

ITLIINWLQEALSSASLAH2507MK

+3

3.39

0.42

+3

5.21

0.56

+3

3.47

0.78

+2

3.79

0.67

+2

3.73

0.06

+2

3.34

0.03

+3

5.56

0.09

P+16

1007

2211-16

1001-24

LELELRP

2223

140-57

QVFLYP145EKDEPTYILNIK

2231
2303-06
2439
2623

3587-3603
655-69
2610-25
3292-3311

ATLELSP

TGEIEQYSVSATYELQR

3593

WQMSALVQVH

663

IEGNLIFDP NNYLPK
ATFQTPDFIVP
VP

2620

LTDLR

3293

SYTLILPSLELPVLHVPR
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Table A-3 List of peptides depicting various modifications observed in tryptic peptides (unique positive match) obtained from apo B-100 after
intermediate peroxide exposure (sample 3). Duplicate run (sample 4) did not reveal any unique peptide.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

F+16

1510

1188-1202

KMTSNF1193PVDLSDYPK.S

+3

3.23

0.09

2419

+2

3.33

0.59

+2

4.94

0.01

+3

3.35

0.34

2433-38
Y+16
P+16

1577
1331-33

2411-25
4499-4512
3996-4021

TFIEDVNKF

LDMLIK

LQDFSDQLSDYY
GISTSAASP

4004

4510

EK

AVGTVGM

4011
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Table A-4 List of peptides depicting various modifications observed in tryptic peptides obtained (unique positive match) from apo B-100 after high
peroxide exposure (sample 5)

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

F+16

1621-27

1189-1202

MTSNF1193PVDLSDYPK

+2

3.11

0.73

2323-27

2645-69

FSTPEFTILNTFHIPSFTIDF2665VEMK

+3

3.93

0.22

+2

4.94

0.01

+3

3.35

0.34

4380

Y+16

2417-23

4359-85

FNEFIQNELQEASQELQQIHQY

P+16

1367-73

3996-4021

GISTSAASP4004AVGTVGM4011DMDEDDDFSK
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Table A-5 List of peptides depicting various modifications observed in tryptic peptides (unique positive match) obtained from apo B-100 after high
peroxide exposure (sample 6)

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

F+16

2113

2296-2309

VLLDQLGTTISF2307ER

+2

3.12

0.52

2301

877-96

PSVSVEF883VTNMGIIIPDFAR

+2

3.27

0.20

2591-99

670-95

ESMLKTTLTAF680GFASADLIEIGLEGK

+3

4.30

0.02

2799-2802

2411-25

TFIEDVNKF2419LDMLIK

+2

3.42

0.63

F+32

2107-11

2296-2309

VLLDQLGTTISF2307ER

+2

4.94

0.01

Y+16

2131-37

2560-75

NLTDFAEQY2568SIQDWAK

+2

4.40

0.07

P+16

1965

3277-91

AVSM3279P3280SFSILGSDVR

+2

3.87

0.65

K+120

2732

2195-2210

K2195IAIANIIDEIIEK2208LK [2208Lys]

+3

3.05

0.01

K+138

2732

2195-2210

K2195IAIANIIDEIIEK2208LK [2195Lys]

+3

3.05

0.01
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Appendix B
Table B-1 List of peptides depicting various modifications observed in tryptic peptides (unique positive match) obtained from apo B-100 after low,
intermediate and high peroxynitrite exposure. All matched peptides were listed in the following table.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

Y+45

4151

1830-52

AY1831QNNEIKHIY1840AISSAALSASYK [1831 hydroxylation of Y]

+3

3.53

0.09

W+16

4569-76

577-90

IVQILPW583EQNEQVK

+2

3.32

0.55

4413-18

3953-73

DFSAEYEEDGKFEGLQEW3970EGK

+3

3.45

0.76

4120

577-90

IVQILPW583EQNEQVK

+2

3.36

0.49

8726-30

3953-73

DFSAEYEEDGKFEGLQEW3970EGK

+3

3.28

0.68

8846-50

3953-73

DFSAEYEEDGKFEGLQEW3970EGK

+3

3.28

0.70

5398-5405

2241-55

SGSSTASW2248IQNVDTK

+2

3.62

0.64

8158-62

1451-74

GLLIFDASSSW1461GPQMSASVHLDSK

+3

3.54

0.66

5562

3953-73

DFSAEYEEDGKFEGLQEW3970EGK

+2

2.60

0.71

8571-76

1499-1513

GTYGLSC1505QRDPNTGR

+2

3.08

0.66

C+48
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Table B-2 List of peptides depicting various modifications observed in tryptic peptides (unique positive match) obtained from apo B-100 after another
high peroxynitrite exposure. Unlike the last time four nitrotyrosines were nitrated. Relevant peptides were listed below.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

Y+45

1382

2523-34

M2523Y2524QM2526DIQQELQR

+2

4.52

0.69

2213-19

3292-3311

VPSY3295TLILPSLELPVLHVPR

+3

6.34

0.61

2807-13

401-27

VHANPLLIDVVTY413LVALIPEPSAQQLR

+3

4.29

0.31

1328

1600-10

SEY1602QADYESLR

+2

2.68

0.50
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Table B-3 List of peptides depicting various modifications observed in pronase digest (unique positive match) obtained from apo B-100 after low,
intermediate and high hypochlorite exposure. All positive matches from duplicate experiments were shown below.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

Y+34

2300-06

1051-67

FKY1053NRQSM1058TLSSEVQIP

+3

3.57

0.29

2619-34

1193-1202

FPVDLSDY1200PK

+2

3.04

0.47

2492-95

1193-1204

FPVDLSDY1200PKSL

+2

3.26

0.43

2405

4010-22

GM4011DM4013DEDDDFSKW4022

+2

3.63

0.57

2268

4385-98

REEYFDPSIVGW4396TV

+2

3.09

0.66

W+16
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Table B-4 List of matched peptides after low hypochlorite treatment followed by a trypsin digestion of apo B-100. All peptides from duplicate analyses
were shown.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

Y+34

2440-43

3292-3311

VPSY3295TLILPSLELPVLHVPR

+3

3.26

0.34

W+16

1702

3559-68

IYSLW3563EHSTK

+2

3.06

0.38
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Table B-5 List of matched peptides after intermediate hypochlorite treatment followed by a trypsin digestion of apo B-100. All peptides from duplicate
analyses were shown.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

W+16

2026

2118-33

LPQQANDYLNSFNW2131ER

+2

4.84

0.61

2098

3587-3603

ATLELSPW3594QMSALVQVH

+2

4.89

0.54

2188

4056-71

VNW4058EEEAASGLLTSLK

+2

4.40

0.62

2271

2675-94

TIDQMQNSELQW2686PVPDIYLR

+2

2.70

0.42

3031

2489-2509

ITLIINW2495LQEALSSASLAHMK

+3

3.04

0.17

3405-23

2535-59

YLSLVGQVYSTLVTYISDW2553W2554TLAAK [could be either]

+2

4.33

0.04

4768

1451-74

GLLIFDASSSW1461GPQMSASVHLDSK

+3

3.43

0.54

1690-95

720-32

YW721VNGQVPDGVSK

+2

3.33

0.61

1537

1102-18

ITEVALM1108GHLSC1112DTKEER

+3

5.22

0.68

1621

1101-18

KITEVALM1108GHLSC1112DTKEER

+3

5.05

0.60

1820-27

4214-22

EELC4217TM4219FIR

+2

2.51

0.55

C+48
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Table B-6 List of matched peptides after high hypochlorite treatment followed by a trypsin digestion of apo B-100. All peptides from duplicate analyses
were shown.

AA modification

Dta #

Peptide

AA sequence for the peptide

Chg.
State

Xc

∆Cn

Y+34

1834-41

276-87

Y276GM278VAQVTQTLK

+2

3.85

0.48

+3

4.31

0.62

+2

5.44

0.22

1877-83
1925
1929-46
2127
2145
2249-53
2299-2307
2441-50
2693-97
3009-14
2202-08
Y+68

2195-97
2345
2588
2734

W+16

2459
3398
1901

C+48

1958

440-54
1985-2002
3763-72
4499-4512
1189-1202
3137-48
140-57
655-69
3292-3311
4520-40
3137-48
4499-4512
140-57
4447-61
3292-3311
3137-55
2335-59
4056-66
3754-66

443

ATLY ALSHAVNNYHK
TQFNNNEYSQDLDAY
LDFREIQIY

1999

NTK

3771

K

+2

2.71

0.25

Y

4510

+2

4.97

0.11

TSNFPVDLSDY

1200

+2

3.61

0.65

TIITTPPLK

+2

3.77

0.59

144

+3

4.13

0.21

+2

3.57

0.48

+2

4.51

0.58

+3

5.72

0.49

+2

3.95

0.58

EK

+2

5.16

0.09

QVFLY PEKDEPTYILNIK

+3

3.73

0.19

+2

4.04

0.69

+3

4.85

0.60

+3

3.95

0.51

+3

4.28

0.25

+2

3.02

0.65

+2

3.06

0.44

LQDFSDQLSDY
M

4509

1189

LPY

EK [could be either one]
PK

3139

QVFLY PEKDEPTYILNIK
666

IEGNLIFDPNNY LPK
VPSY

3295

TLILPSLELPVLHVPR

LIDLSIQNYHTFLIY
LPY

4534

ITELLK

3139

TIITTPPLK

LQDFSDQLSDY

4509

Y

4510

148

NIQEY
VPSY

4451

LSILTDPDGK

3295

TLILPSLELPVLHVPR

LPYTIITTPPLKDFSLW

3153

EK

YLSLVGQVYSTLVTYISDW
VNW

4058

EEEAASGL
3761

TDLQVPSC

KLDFR

208

2553

W

2554

TLAAK [both oxidized]
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